Motif ID: ELF2_GABPA_ELF5
Z-value: 4.163
Top targets:
Gene overrepresentation in biological_process category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 3.0 | 9.1 | GO:0002431 | Fc receptor mediated stimulatory signaling pathway(GO:0002431) regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) positive regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060369) |
| 2.7 | 10.9 | GO:0048478 | replication fork protection(GO:0048478) |
| 2.7 | 8.0 | GO:1904036 | negative regulation of epithelial cell apoptotic process(GO:1904036) negative regulation of endothelial cell apoptotic process(GO:2000352) |
| 2.2 | 6.5 | GO:0031167 | rRNA methylation(GO:0031167) |
| 2.1 | 8.3 | GO:0009146 | purine nucleoside triphosphate catabolic process(GO:0009146) purine deoxyribonucleotide catabolic process(GO:0009155) deoxyribonucleoside triphosphate catabolic process(GO:0009204) purine deoxyribonucleoside triphosphate catabolic process(GO:0009217) DNA protection(GO:0042262) |
| 1.5 | 3.0 | GO:0001833 | inner cell mass cell proliferation(GO:0001833) |
| 1.5 | 4.6 | GO:0006427 | histidyl-tRNA aminoacylation(GO:0006427) |
| 1.5 | 1.5 | GO:0002260 | lymphocyte homeostasis(GO:0002260) |
| 1.5 | 5.9 | GO:0051503 | adenine nucleotide transport(GO:0051503) |
| 1.4 | 4.2 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
| 1.4 | 5.4 | GO:0009221 | pyrimidine deoxyribonucleotide biosynthetic process(GO:0009221) |
| 1.2 | 2.5 | GO:0001832 | blastocyst growth(GO:0001832) |
| 1.2 | 7.2 | GO:0050857 | positive regulation of antigen receptor-mediated signaling pathway(GO:0050857) |
| 1.2 | 4.7 | GO:0006089 | lactate metabolic process(GO:0006089) |
| 1.1 | 3.3 | GO:0051231 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) |
| 1.1 | 1.1 | GO:0002681 | somatic diversification of T cell receptor genes(GO:0002568) somatic recombination of T cell receptor gene segments(GO:0002681) T cell receptor V(D)J recombination(GO:0033153) |
| 1.1 | 1.1 | GO:0045048 | protein insertion into ER membrane(GO:0045048) tail-anchored membrane protein insertion into ER membrane(GO:0071816) |
| 1.1 | 4.3 | GO:0071025 | RNA surveillance(GO:0071025) nuclear RNA surveillance(GO:0071027) nuclear mRNA surveillance(GO:0071028) |
| 1.1 | 3.2 | GO:0071104 | response to interleukin-9(GO:0071104) response to interleukin-11(GO:0071105) |
| 1.0 | 3.1 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) cytoplasmic translation(GO:0002181) cytoplasmic translational initiation(GO:0002183) |
| 1.0 | 7.0 | GO:0045010 | actin nucleation(GO:0045010) |
| 1.0 | 24.6 | GO:0002504 | antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002504) |
| 1.0 | 3.9 | GO:0000012 | single strand break repair(GO:0000012) |
| 1.0 | 2.9 | GO:0043366 | beta selection(GO:0043366) |
| 1.0 | 2.9 | GO:0006597 | spermine biosynthetic process(GO:0006597) |
| 0.9 | 2.8 | GO:0000738 | DNA catabolic process, exonucleolytic(GO:0000738) |
| 0.9 | 4.6 | GO:0007144 | female meiosis I(GO:0007144) |
| 0.9 | 3.6 | GO:0001807 | type IV hypersensitivity(GO:0001806) regulation of type IV hypersensitivity(GO:0001807) |
| 0.9 | 1.8 | GO:0060547 | negative regulation of necrotic cell death(GO:0060547) |
| 0.9 | 0.9 | GO:0046619 | optic placode formation involved in camera-type eye formation(GO:0046619) |
| 0.9 | 3.5 | GO:0042231 | interleukin-13 biosynthetic process(GO:0042231) |
| 0.9 | 2.6 | GO:0050983 | spermidine catabolic process(GO:0046203) deoxyhypusine biosynthetic process from spermidine(GO:0050983) |
| 0.9 | 2.6 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
| 0.9 | 4.3 | GO:2001259 | positive regulation of calcium ion transmembrane transporter activity(GO:1901021) positive regulation of cation channel activity(GO:2001259) |
| 0.8 | 0.8 | GO:0036037 | CD8-positive, alpha-beta T cell activation(GO:0036037) CD8-positive, alpha-beta T cell differentiation(GO:0043374) |
| 0.8 | 5.0 | GO:0060263 | regulation of respiratory burst(GO:0060263) |
| 0.8 | 1.7 | GO:0007096 | regulation of exit from mitosis(GO:0007096) |
| 0.8 | 2.4 | GO:0000154 | rRNA modification(GO:0000154) |
| 0.8 | 6.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
| 0.8 | 2.4 | GO:0018916 | nitrobenzene metabolic process(GO:0018916) |
| 0.8 | 3.2 | GO:0034086 | maintenance of sister chromatid cohesion(GO:0034086) maintenance of mitotic sister chromatid cohesion(GO:0034088) |
| 0.8 | 1.6 | GO:0036260 | 7-methylguanosine mRNA capping(GO:0006370) 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
| 0.8 | 3.1 | GO:0090267 | positive regulation of spindle checkpoint(GO:0090232) regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090266) positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) positive regulation of cell cycle checkpoint(GO:1901978) regulation of mitotic spindle checkpoint(GO:1903504) |
| 0.8 | 6.2 | GO:0045003 | DNA recombinase assembly(GO:0000730) double-strand break repair via synthesis-dependent strand annealing(GO:0045003) |
| 0.8 | 3.0 | GO:0045356 | positive regulation of interferon-alpha biosynthetic process(GO:0045356) |
| 0.8 | 11.3 | GO:0051103 | DNA ligation involved in DNA repair(GO:0051103) |
| 0.7 | 0.7 | GO:0046102 | inosine metabolic process(GO:0046102) |
| 0.7 | 0.7 | GO:0006998 | nuclear envelope organization(GO:0006998) |
| 0.7 | 2.2 | GO:0018283 | metal incorporation into metallo-sulfur cluster(GO:0018282) iron incorporation into metallo-sulfur cluster(GO:0018283) |
| 0.7 | 0.7 | GO:0045350 | interferon-beta biosynthetic process(GO:0045350) regulation of interferon-beta biosynthetic process(GO:0045357) positive regulation of interferon-beta biosynthetic process(GO:0045359) |
| 0.7 | 2.1 | GO:0010501 | RNA secondary structure unwinding(GO:0010501) |
| 0.7 | 3.5 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
| 0.7 | 3.5 | GO:0017183 | peptidyl-diphthamide metabolic process(GO:0017182) peptidyl-diphthamide biosynthetic process from peptidyl-histidine(GO:0017183) |
| 0.7 | 2.8 | GO:0032928 | regulation of superoxide anion generation(GO:0032928) negative regulation of superoxide anion generation(GO:0032929) |
| 0.7 | 3.4 | GO:0006189 | 'de novo' IMP biosynthetic process(GO:0006189) |
| 0.7 | 2.1 | GO:0032581 | ER-dependent peroxisome organization(GO:0032581) |
| 0.7 | 4.1 | GO:0043316 | natural killer cell activation involved in immune response(GO:0002323) cytotoxic T cell degranulation(GO:0043316) natural killer cell degranulation(GO:0043320) |
| 0.7 | 2.7 | GO:0016584 | nucleosome positioning(GO:0016584) |
| 0.7 | 1.4 | GO:0033002 | muscle cell proliferation(GO:0033002) smooth muscle cell proliferation(GO:0048659) |
| 0.7 | 19.6 | GO:0006271 | DNA strand elongation involved in DNA replication(GO:0006271) |
| 0.7 | 5.4 | GO:0051096 | positive regulation of helicase activity(GO:0051096) |
| 0.7 | 6.7 | GO:0016180 | snRNA processing(GO:0016180) |
| 0.7 | 5.3 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) transcription from mitochondrial promoter(GO:0006390) |
| 0.7 | 3.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
| 0.7 | 2.0 | GO:0046599 | regulation of centriole replication(GO:0046599) |
| 0.7 | 2.0 | GO:1901724 | response to heparin(GO:0071503) cellular response to heparin(GO:0071504) positive regulation of cell proliferation involved in kidney development(GO:1901724) |
| 0.6 | 3.2 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
| 0.6 | 1.3 | GO:0010957 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) negative regulation of vitamin D biosynthetic process(GO:0010957) negative regulation of vitamin metabolic process(GO:0046137) |
| 0.6 | 13.3 | GO:0000291 | nuclear-transcribed mRNA catabolic process, exonucleolytic(GO:0000291) exonucleolytic nuclear-transcribed mRNA catabolic process involved in deadenylation-dependent decay(GO:0043928) |
| 0.6 | 1.3 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) sodium ion homeostasis(GO:0055078) |
| 0.6 | 4.4 | GO:0034616 | response to laminar fluid shear stress(GO:0034616) |
| 0.6 | 1.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
| 0.6 | 5.3 | GO:0051290 | protein heterotetramerization(GO:0051290) |
| 0.6 | 2.4 | GO:0000463 | maturation of LSU-rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000463) maturation of LSU-rRNA(GO:0000470) |
| 0.6 | 9.4 | GO:0032508 | DNA geometric change(GO:0032392) DNA duplex unwinding(GO:0032508) |
| 0.6 | 15.2 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
| 0.6 | 2.3 | GO:0071436 | sodium ion export(GO:0071436) |
| 0.6 | 3.5 | GO:0015853 | adenine transport(GO:0015853) |
| 0.6 | 1.7 | GO:0000917 | barrier septum assembly(GO:0000917) cell septum assembly(GO:0090529) mitotic cytokinetic process(GO:1902410) |
| 0.6 | 2.8 | GO:0006658 | phosphatidylserine metabolic process(GO:0006658) |
| 0.6 | 2.8 | GO:0008053 | mitochondrial fusion(GO:0008053) |
| 0.6 | 6.7 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
| 0.5 | 3.3 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
| 0.5 | 4.9 | GO:0030903 | notochord development(GO:0030903) |
| 0.5 | 5.4 | GO:0006379 | mRNA cleavage(GO:0006379) |
| 0.5 | 2.1 | GO:0071894 | histone H2B conserved C-terminal lysine ubiquitination(GO:0071894) |
| 0.5 | 1.6 | GO:0043095 | regulation of GTP cyclohydrolase I activity(GO:0043095) negative regulation of GTP cyclohydrolase I activity(GO:0043105) |
| 0.5 | 3.7 | GO:0045040 | outer mitochondrial membrane organization(GO:0007008) protein import into mitochondrial outer membrane(GO:0045040) |
| 0.5 | 4.2 | GO:0045039 | protein import into mitochondrial inner membrane(GO:0045039) establishment of protein localization to mitochondrial membrane(GO:0090151) |
| 0.5 | 2.6 | GO:0034204 | lipid translocation(GO:0034204) phospholipid translocation(GO:0045332) |
| 0.5 | 2.1 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
| 0.5 | 3.1 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
| 0.5 | 2.6 | GO:0060397 | JAK-STAT cascade involved in growth hormone signaling pathway(GO:0060397) |
| 0.5 | 0.5 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
| 0.5 | 1.5 | GO:0070816 | phosphorylation of RNA polymerase II C-terminal domain(GO:0070816) |
| 0.5 | 9.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
| 0.5 | 1.5 | GO:1901798 | positive regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043517) positive regulation of signal transduction by p53 class mediator(GO:1901798) |
| 0.5 | 1.0 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
| 0.5 | 1.0 | GO:0006549 | isoleucine metabolic process(GO:0006549) |
| 0.5 | 1.5 | GO:0048681 | negative regulation of axon regeneration(GO:0048681) negative regulation of neuron projection regeneration(GO:0070571) |
| 0.5 | 5.9 | GO:0071378 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
| 0.5 | 0.5 | GO:0018022 | peptidyl-lysine methylation(GO:0018022) |
| 0.5 | 4.4 | GO:0006020 | inositol metabolic process(GO:0006020) |
| 0.5 | 9.8 | GO:0008625 | extrinsic apoptotic signaling pathway via death domain receptors(GO:0008625) extrinsic apoptotic signaling pathway(GO:0097191) |
| 0.5 | 2.0 | GO:0009106 | lipoate metabolic process(GO:0009106) |
| 0.5 | 4.9 | GO:0006734 | NADH metabolic process(GO:0006734) |
| 0.5 | 4.9 | GO:0015074 | DNA integration(GO:0015074) |
| 0.5 | 9.6 | GO:0009303 | rRNA transcription(GO:0009303) |
| 0.5 | 0.5 | GO:0031642 | negative regulation of myelination(GO:0031642) |
| 0.5 | 1.4 | GO:0046080 | dUTP metabolic process(GO:0046080) |
| 0.5 | 2.3 | GO:0006436 | tryptophanyl-tRNA aminoacylation(GO:0006436) |
| 0.5 | 2.8 | GO:0042415 | norepinephrine metabolic process(GO:0042415) |
| 0.5 | 4.2 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
| 0.5 | 6.4 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
| 0.5 | 3.7 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
| 0.5 | 1.8 | GO:0060025 | regulation of synaptic activity(GO:0060025) |
| 0.5 | 15.9 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
| 0.5 | 2.3 | GO:0032876 | regulation of DNA endoreduplication(GO:0032875) negative regulation of DNA endoreduplication(GO:0032876) DNA endoreduplication(GO:0042023) |
| 0.5 | 1.8 | GO:0000491 | small nucleolar ribonucleoprotein complex assembly(GO:0000491) box C/D snoRNP assembly(GO:0000492) |
| 0.5 | 2.7 | GO:0043985 | histone H4-R3 methylation(GO:0043985) |
| 0.5 | 3.6 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
| 0.4 | 0.9 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
| 0.4 | 0.4 | GO:0006553 | lysine metabolic process(GO:0006553) lysine catabolic process(GO:0006554) |
| 0.4 | 4.5 | GO:0002092 | positive regulation of receptor internalization(GO:0002092) |
| 0.4 | 1.8 | GO:0035025 | positive regulation of Rho protein signal transduction(GO:0035025) |
| 0.4 | 2.2 | GO:0032329 | serine transport(GO:0032329) |
| 0.4 | 3.5 | GO:0045008 | depyrimidination(GO:0045008) |
| 0.4 | 2.6 | GO:0007256 | activation of JNKK activity(GO:0007256) |
| 0.4 | 11.0 | GO:0043486 | histone exchange(GO:0043486) |
| 0.4 | 0.9 | GO:0045046 | protein import into peroxisome membrane(GO:0045046) |
| 0.4 | 5.2 | GO:0006108 | malate metabolic process(GO:0006108) |
| 0.4 | 2.6 | GO:0022614 | membrane to membrane docking(GO:0022614) |
| 0.4 | 1.3 | GO:0003171 | atrioventricular valve development(GO:0003171) atrioventricular valve morphogenesis(GO:0003181) negative regulation of Wnt signaling pathway involved in heart development(GO:0003308) |
| 0.4 | 1.3 | GO:0003351 | epithelial cilium movement(GO:0003351) epithelial cilium movement involved in determination of left/right asymmetry(GO:0060287) |
| 0.4 | 1.7 | GO:0007352 | zygotic specification of dorsal/ventral axis(GO:0007352) |
| 0.4 | 2.5 | GO:0042769 | DNA damage response, detection of DNA damage(GO:0042769) |
| 0.4 | 1.3 | GO:0030500 | regulation of bone mineralization(GO:0030500) |
| 0.4 | 6.7 | GO:0006400 | tRNA modification(GO:0006400) |
| 0.4 | 2.5 | GO:0051299 | centrosome separation(GO:0051299) |
| 0.4 | 0.4 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) positive regulation of hematopoietic progenitor cell differentiation(GO:1901534) |
| 0.4 | 0.4 | GO:0009067 | aspartate family amino acid biosynthetic process(GO:0009067) |
| 0.4 | 1.2 | GO:0016926 | protein desumoylation(GO:0016926) |
| 0.4 | 0.8 | GO:0051852 | disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) |
| 0.4 | 1.2 | GO:0032025 | response to cobalt ion(GO:0032025) |
| 0.4 | 2.1 | GO:0010447 | response to acidic pH(GO:0010447) |
| 0.4 | 1.6 | GO:0043653 | mitochondrial fragmentation involved in apoptotic process(GO:0043653) |
| 0.4 | 1.6 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
| 0.4 | 50.3 | GO:0042254 | ribosome biogenesis(GO:0042254) |
| 0.4 | 2.0 | GO:0045767 | obsolete regulation of anti-apoptosis(GO:0045767) |
| 0.4 | 2.4 | GO:0015742 | alpha-ketoglutarate transport(GO:0015742) |
| 0.4 | 0.4 | GO:0007109 | obsolete cytokinesis, completion of separation(GO:0007109) |
| 0.4 | 1.6 | GO:1904035 | endothelial cell apoptotic process(GO:0072577) epithelial cell apoptotic process(GO:1904019) regulation of epithelial cell apoptotic process(GO:1904035) regulation of endothelial cell apoptotic process(GO:2000351) |
| 0.4 | 2.4 | GO:0032897 | negative regulation of viral transcription(GO:0032897) |
| 0.4 | 11.5 | GO:0006626 | protein targeting to mitochondrion(GO:0006626) |
| 0.4 | 2.4 | GO:0006196 | AMP catabolic process(GO:0006196) |
| 0.4 | 1.6 | GO:0051013 | microtubule severing(GO:0051013) |
| 0.4 | 0.4 | GO:0033261 | obsolete regulation of S phase(GO:0033261) |
| 0.4 | 1.2 | GO:0060152 | peroxisome localization(GO:0060151) microtubule-based peroxisome localization(GO:0060152) |
| 0.4 | 1.2 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) DNA dealkylation(GO:0035510) |
| 0.4 | 1.2 | GO:0003056 | regulation of vascular smooth muscle contraction(GO:0003056) |
| 0.4 | 1.9 | GO:0060999 | positive regulation of dendritic spine development(GO:0060999) positive regulation of dendritic spine morphogenesis(GO:0061003) |
| 0.4 | 1.1 | GO:0051709 | regulation of killing of cells of other organism(GO:0051709) |
| 0.4 | 0.8 | GO:0040016 | embryonic cleavage(GO:0040016) |
| 0.4 | 1.1 | GO:0008637 | apoptotic mitochondrial changes(GO:0008637) |
| 0.4 | 1.9 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
| 0.4 | 1.9 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
| 0.4 | 4.2 | GO:0001706 | endoderm formation(GO:0001706) |
| 0.4 | 10.6 | GO:0060334 | regulation of response to interferon-gamma(GO:0060330) regulation of interferon-gamma-mediated signaling pathway(GO:0060334) |
| 0.4 | 1.5 | GO:0032959 | inositol trisphosphate biosynthetic process(GO:0032959) |
| 0.4 | 3.0 | GO:0010922 | positive regulation of phosphatase activity(GO:0010922) |
| 0.4 | 4.8 | GO:0071158 | positive regulation of cell cycle arrest(GO:0071158) |
| 0.4 | 1.1 | GO:0000059 | protein import into nucleus, docking(GO:0000059) |
| 0.4 | 6.6 | GO:1904031 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
| 0.4 | 0.7 | GO:0002360 | T cell lineage commitment(GO:0002360) |
| 0.4 | 1.5 | GO:0043248 | proteasome assembly(GO:0043248) |
| 0.4 | 1.8 | GO:0044380 | protein localization to cytoskeleton(GO:0044380) protein localization to microtubule cytoskeleton(GO:0072698) |
| 0.4 | 2.2 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
| 0.4 | 0.7 | GO:0034723 | DNA replication-dependent nucleosome organization(GO:0034723) |
| 0.4 | 1.8 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
| 0.4 | 2.2 | GO:1901503 | ether lipid biosynthetic process(GO:0008611) glycerol ether biosynthetic process(GO:0046504) ether biosynthetic process(GO:1901503) |
| 0.4 | 1.1 | GO:0021571 | rhombomere 5 development(GO:0021571) |
| 0.4 | 2.2 | GO:0035246 | peptidyl-arginine N-methylation(GO:0035246) |
| 0.4 | 2.5 | GO:0051123 | RNA polymerase II transcriptional preinitiation complex assembly(GO:0051123) DNA-templated transcriptional preinitiation complex assembly(GO:0070897) |
| 0.4 | 12.4 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
| 0.4 | 0.4 | GO:0070842 | aggresome assembly(GO:0070842) |
| 0.4 | 0.4 | GO:0090312 | regulation of protein deacetylation(GO:0090311) positive regulation of protein deacetylation(GO:0090312) |
| 0.3 | 2.1 | GO:0055091 | phospholipid homeostasis(GO:0055091) |
| 0.3 | 1.0 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
| 0.3 | 32.5 | GO:0000216 | obsolete M/G1 transition of mitotic cell cycle(GO:0000216) |
| 0.3 | 1.0 | GO:0060743 | epithelial cell maturation involved in prostate gland development(GO:0060743) |
| 0.3 | 4.8 | GO:0046827 | positive regulation of protein export from nucleus(GO:0046827) |
| 0.3 | 1.0 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
| 0.3 | 1.7 | GO:0071569 | protein ufmylation(GO:0071569) |
| 0.3 | 10.1 | GO:0000080 | mitotic G1 phase(GO:0000080) |
| 0.3 | 1.3 | GO:0045410 | positive regulation of interleukin-6 biosynthetic process(GO:0045410) |
| 0.3 | 2.0 | GO:0006361 | transcription initiation from RNA polymerase I promoter(GO:0006361) |
| 0.3 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
| 0.3 | 1.0 | GO:0006432 | phenylalanyl-tRNA aminoacylation(GO:0006432) |
| 0.3 | 15.0 | GO:0050434 | positive regulation of viral transcription(GO:0050434) |
| 0.3 | 1.6 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
| 0.3 | 4.5 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
| 0.3 | 1.6 | GO:1903901 | negative regulation of viral process(GO:0048525) negative regulation of viral life cycle(GO:1903901) |
| 0.3 | 1.0 | GO:0009143 | nucleoside triphosphate catabolic process(GO:0009143) |
| 0.3 | 2.6 | GO:0006600 | creatine metabolic process(GO:0006600) |
| 0.3 | 2.8 | GO:0006516 | glycoprotein catabolic process(GO:0006516) |
| 0.3 | 1.2 | GO:0060649 | nipple development(GO:0060618) mammary gland bud elongation(GO:0060649) nipple morphogenesis(GO:0060658) nipple sheath formation(GO:0060659) |
| 0.3 | 1.8 | GO:0003032 | detection of oxygen(GO:0003032) |
| 0.3 | 0.3 | GO:2000109 | regulation of toll-like receptor 2 signaling pathway(GO:0034135) macrophage apoptotic process(GO:0071888) regulation of macrophage apoptotic process(GO:2000109) |
| 0.3 | 0.9 | GO:0043370 | regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043370) positive regulation of CD4-positive, alpha-beta T cell differentiation(GO:0043372) regulation of CD4-positive, alpha-beta T cell activation(GO:2000514) positive regulation of CD4-positive, alpha-beta T cell activation(GO:2000516) |
| 0.3 | 1.8 | GO:0006983 | ER overload response(GO:0006983) |
| 0.3 | 0.9 | GO:0006782 | protoporphyrinogen IX biosynthetic process(GO:0006782) |
| 0.3 | 2.7 | GO:0090398 | cellular senescence(GO:0090398) |
| 0.3 | 4.2 | GO:0006376 | mRNA splice site selection(GO:0006376) |
| 0.3 | 0.9 | GO:0070781 | response to biotin(GO:0070781) |
| 0.3 | 1.8 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
| 0.3 | 0.9 | GO:0000338 | protein deneddylation(GO:0000338) |
| 0.3 | 0.9 | GO:0070935 | 3'-UTR-mediated mRNA stabilization(GO:0070935) |
| 0.3 | 1.5 | GO:0060710 | chorio-allantoic fusion(GO:0060710) |
| 0.3 | 2.3 | GO:0043558 | regulation of translational initiation in response to stress(GO:0043558) |
| 0.3 | 0.6 | GO:0051901 | positive regulation of mitochondrial depolarization(GO:0051901) positive regulation of membrane depolarization(GO:1904181) |
| 0.3 | 2.0 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
| 0.3 | 2.9 | GO:0000184 | nuclear-transcribed mRNA catabolic process, nonsense-mediated decay(GO:0000184) |
| 0.3 | 0.9 | GO:1901796 | regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043516) regulation of signal transduction by p53 class mediator(GO:1901796) |
| 0.3 | 1.1 | GO:0043128 | regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043126) positive regulation of 1-phosphatidylinositol 4-kinase activity(GO:0043128) |
| 0.3 | 0.8 | GO:0071848 | regulation of fever generation by regulation of prostaglandin secretion(GO:0071810) positive regulation of fever generation by positive regulation of prostaglandin secretion(GO:0071812) TNFSF11-mediated signaling pathway(GO:0071847) positive regulation of ERK1 and ERK2 cascade via TNFSF11-mediated signaling(GO:0071848) regulation of fever generation by prostaglandin secretion(GO:0100009) |
| 0.3 | 0.6 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
| 0.3 | 0.8 | GO:0046826 | negative regulation of protein export from nucleus(GO:0046826) |
| 0.3 | 0.6 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
| 0.3 | 1.4 | GO:0060017 | parathyroid gland development(GO:0060017) |
| 0.3 | 1.1 | GO:0009223 | pyrimidine deoxyribonucleotide catabolic process(GO:0009223) |
| 0.3 | 1.1 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
| 0.3 | 3.8 | GO:0055070 | copper ion homeostasis(GO:0055070) |
| 0.3 | 0.8 | GO:0001954 | positive regulation of cell-matrix adhesion(GO:0001954) |
| 0.3 | 3.6 | GO:0032703 | negative regulation of interleukin-2 production(GO:0032703) |
| 0.3 | 2.7 | GO:0006825 | copper ion transport(GO:0006825) |
| 0.3 | 0.5 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
| 0.3 | 4.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
| 0.3 | 1.6 | GO:0034508 | centromere complex assembly(GO:0034508) |
| 0.3 | 5.1 | GO:0070206 | protein trimerization(GO:0070206) |
| 0.3 | 12.6 | GO:0008033 | tRNA processing(GO:0008033) |
| 0.3 | 1.1 | GO:0021978 | telencephalon regionalization(GO:0021978) |
| 0.3 | 1.1 | GO:0007130 | meiosis I(GO:0007127) synaptonemal complex assembly(GO:0007130) |
| 0.3 | 2.9 | GO:0007059 | chromosome segregation(GO:0007059) |
| 0.3 | 1.3 | GO:0006857 | oligopeptide transport(GO:0006857) |
| 0.3 | 0.8 | GO:0072387 | flavin adenine dinucleotide metabolic process(GO:0072387) |
| 0.3 | 0.8 | GO:0043116 | negative regulation of vascular permeability(GO:0043116) |
| 0.3 | 2.6 | GO:0033108 | mitochondrial respiratory chain complex assembly(GO:0033108) |
| 0.3 | 3.4 | GO:0046655 | folic acid metabolic process(GO:0046655) |
| 0.3 | 3.9 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
| 0.3 | 1.6 | GO:0071361 | cellular response to ethanol(GO:0071361) |
| 0.3 | 4.1 | GO:0007020 | microtubule nucleation(GO:0007020) |
| 0.3 | 2.1 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
| 0.3 | 0.3 | GO:0014045 | establishment of endothelial blood-brain barrier(GO:0014045) central nervous system vasculogenesis(GO:0022009) |
| 0.3 | 14.3 | GO:0060333 | interferon-gamma-mediated signaling pathway(GO:0060333) |
| 0.3 | 0.5 | GO:0072207 | metanephric tubule development(GO:0072170) metanephric epithelium development(GO:0072207) metanephric nephron tubule development(GO:0072234) metanephric nephron epithelium development(GO:0072243) |
| 0.3 | 1.3 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
| 0.3 | 0.5 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
| 0.3 | 1.8 | GO:0008334 | histone mRNA metabolic process(GO:0008334) |
| 0.3 | 0.3 | GO:0032506 | cytokinetic process(GO:0032506) |
| 0.3 | 1.8 | GO:0000185 | activation of MAPKKK activity(GO:0000185) |
| 0.3 | 2.3 | GO:0001556 | oocyte maturation(GO:0001556) |
| 0.2 | 0.7 | GO:0045084 | positive regulation of interleukin-12 biosynthetic process(GO:0045084) |
| 0.2 | 1.7 | GO:0070934 | CRD-mediated mRNA stabilization(GO:0070934) |
| 0.2 | 32.5 | GO:0022904 | respiratory electron transport chain(GO:0022904) |
| 0.2 | 1.0 | GO:0018352 | glutamate decarboxylation to succinate(GO:0006540) protein-pyridoxal-5-phosphate linkage(GO:0018352) |
| 0.2 | 0.7 | GO:0016082 | synaptic vesicle priming(GO:0016082) |
| 0.2 | 0.2 | GO:0033197 | response to vitamin E(GO:0033197) |
| 0.2 | 0.2 | GO:0039656 | modulation by virus of host gene expression(GO:0039656) modification by virus of host mRNA processing(GO:0046778) |
| 0.2 | 0.7 | GO:0032465 | regulation of cytokinesis(GO:0032465) |
| 0.2 | 3.1 | GO:0045540 | regulation of cholesterol biosynthetic process(GO:0045540) |
| 0.2 | 1.0 | GO:0071353 | cellular response to interleukin-4(GO:0071353) |
| 0.2 | 0.7 | GO:0051083 | 'de novo' cotranslational protein folding(GO:0051083) |
| 0.2 | 1.0 | GO:0045338 | farnesyl diphosphate metabolic process(GO:0045338) |
| 0.2 | 1.0 | GO:0046831 | regulation of RNA export from nucleus(GO:0046831) |
| 0.2 | 0.9 | GO:0045199 | maintenance of epithelial cell apical/basal polarity(GO:0045199) |
| 0.2 | 1.2 | GO:0015862 | uridine transport(GO:0015862) |
| 0.2 | 0.7 | GO:0006105 | succinate metabolic process(GO:0006105) |
| 0.2 | 0.7 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
| 0.2 | 2.1 | GO:0060119 | auditory receptor cell development(GO:0060117) inner ear receptor cell development(GO:0060119) |
| 0.2 | 1.2 | GO:0015693 | magnesium ion transport(GO:0015693) |
| 0.2 | 0.5 | GO:0015920 | lipopolysaccharide transport(GO:0015920) |
| 0.2 | 3.9 | GO:0006906 | vesicle fusion(GO:0006906) |
| 0.2 | 0.2 | GO:0009048 | dosage compensation by inactivation of X chromosome(GO:0009048) |
| 0.2 | 0.2 | GO:0032075 | positive regulation of nuclease activity(GO:0032075) |
| 0.2 | 17.2 | GO:0000236 | mitotic prometaphase(GO:0000236) |
| 0.2 | 1.6 | GO:0040032 | post-embryonic body morphogenesis(GO:0040032) |
| 0.2 | 1.1 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
| 0.2 | 1.8 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
| 0.2 | 0.7 | GO:0007386 | compartment pattern specification(GO:0007386) |
| 0.2 | 2.0 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
| 0.2 | 1.8 | GO:0060123 | regulation of growth hormone secretion(GO:0060123) |
| 0.2 | 0.2 | GO:0010944 | negative regulation of transcription by competitive promoter binding(GO:0010944) |
| 0.2 | 9.9 | GO:0030183 | B cell differentiation(GO:0030183) |
| 0.2 | 0.2 | GO:0070584 | mitochondrion morphogenesis(GO:0070584) |
| 0.2 | 0.2 | GO:0007492 | endoderm development(GO:0007492) |
| 0.2 | 2.2 | GO:0030157 | pancreatic juice secretion(GO:0030157) |
| 0.2 | 0.9 | GO:0006768 | biotin metabolic process(GO:0006768) |
| 0.2 | 2.2 | GO:0097035 | regulation of membrane lipid distribution(GO:0097035) |
| 0.2 | 0.2 | GO:0046110 | xanthine metabolic process(GO:0046110) |
| 0.2 | 0.4 | GO:0001543 | ovarian follicle rupture(GO:0001543) |
| 0.2 | 0.6 | GO:0032747 | positive regulation of interleukin-23 production(GO:0032747) |
| 0.2 | 4.5 | GO:0016254 | preassembly of GPI anchor in ER membrane(GO:0016254) |
| 0.2 | 1.5 | GO:0061101 | neuroendocrine cell differentiation(GO:0061101) |
| 0.2 | 15.3 | GO:0006413 | translational initiation(GO:0006413) |
| 0.2 | 0.9 | GO:0033147 | negative regulation of intracellular estrogen receptor signaling pathway(GO:0033147) |
| 0.2 | 5.1 | GO:0050999 | regulation of nitric-oxide synthase activity(GO:0050999) |
| 0.2 | 0.4 | GO:0090174 | organelle membrane fusion(GO:0090174) |
| 0.2 | 1.7 | GO:0007126 | meiotic nuclear division(GO:0007126) |
| 0.2 | 1.1 | GO:0000380 | alternative mRNA splicing, via spliceosome(GO:0000380) |
| 0.2 | 0.6 | GO:0019242 | methylglyoxal biosynthetic process(GO:0019242) |
| 0.2 | 0.4 | GO:0045616 | regulation of keratinocyte differentiation(GO:0045616) |
| 0.2 | 0.4 | GO:0055067 | monovalent inorganic cation homeostasis(GO:0055067) |
| 0.2 | 2.3 | GO:0034643 | establishment of mitochondrion localization, microtubule-mediated(GO:0034643) mitochondrion transport along microtubule(GO:0047497) |
| 0.2 | 2.3 | GO:1902603 | carnitine shuttle(GO:0006853) carnitine transmembrane transport(GO:1902603) |
| 0.2 | 1.9 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
| 0.2 | 0.4 | GO:0033145 | positive regulation of intracellular steroid hormone receptor signaling pathway(GO:0033145) |
| 0.2 | 0.8 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
| 0.2 | 0.6 | GO:0045603 | positive regulation of endothelial cell differentiation(GO:0045603) |
| 0.2 | 3.2 | GO:0045745 | positive regulation of G-protein coupled receptor protein signaling pathway(GO:0045745) |
| 0.2 | 1.8 | GO:0048712 | negative regulation of astrocyte differentiation(GO:0048712) |
| 0.2 | 1.6 | GO:0071300 | cellular response to retinoic acid(GO:0071300) |
| 0.2 | 2.2 | GO:0042531 | positive regulation of tyrosine phosphorylation of STAT protein(GO:0042531) |
| 0.2 | 5.0 | GO:0045333 | cellular respiration(GO:0045333) |
| 0.2 | 0.6 | GO:0006382 | adenosine to inosine editing(GO:0006382) |
| 0.2 | 0.6 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
| 0.2 | 0.6 | GO:0006287 | base-excision repair, gap-filling(GO:0006287) |
| 0.2 | 0.8 | GO:0030259 | lipid glycosylation(GO:0030259) |
| 0.2 | 0.4 | GO:0019059 | obsolete initiation of viral infection(GO:0019059) |
| 0.2 | 5.4 | GO:0048278 | membrane docking(GO:0022406) vesicle docking(GO:0048278) |
| 0.2 | 0.6 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
| 0.2 | 5.4 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
| 0.2 | 0.8 | GO:0031580 | membrane raft polarization(GO:0001766) membrane raft organization(GO:0031579) membrane raft distribution(GO:0031580) |
| 0.2 | 0.9 | GO:0046580 | negative regulation of Ras protein signal transduction(GO:0046580) negative regulation of small GTPase mediated signal transduction(GO:0051058) |
| 0.2 | 5.3 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) positive regulation of proteasomal protein catabolic process(GO:1901800) |
| 0.2 | 3.2 | GO:0050930 | induction of positive chemotaxis(GO:0050930) |
| 0.2 | 0.4 | GO:0016233 | telomere capping(GO:0016233) |
| 0.2 | 0.4 | GO:0051323 | metaphase(GO:0051323) |
| 0.2 | 0.2 | GO:0051592 | response to calcium ion(GO:0051592) |
| 0.2 | 0.6 | GO:0021896 | forebrain astrocyte differentiation(GO:0021896) forebrain astrocyte development(GO:0021897) |
| 0.2 | 0.7 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
| 0.2 | 2.9 | GO:0045815 | positive regulation of gene expression, epigenetic(GO:0045815) |
| 0.2 | 1.1 | GO:0032527 | retrograde protein transport, ER to cytosol(GO:0030970) protein exit from endoplasmic reticulum(GO:0032527) |
| 0.2 | 1.3 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
| 0.2 | 0.5 | GO:0006929 | substrate-dependent cell migration(GO:0006929) |
| 0.2 | 0.7 | GO:0046952 | ketone body catabolic process(GO:0046952) |
| 0.2 | 1.1 | GO:0046834 | lipid phosphorylation(GO:0046834) |
| 0.2 | 1.4 | GO:0061077 | chaperone-mediated protein folding(GO:0061077) |
| 0.2 | 0.9 | GO:0071157 | negative regulation of cell cycle arrest(GO:0071157) |
| 0.2 | 4.1 | GO:0030224 | monocyte differentiation(GO:0030224) |
| 0.2 | 8.5 | GO:0051092 | positive regulation of NF-kappaB transcription factor activity(GO:0051092) |
| 0.2 | 1.1 | GO:0015840 | urea transport(GO:0015840) |
| 0.2 | 0.5 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
| 0.2 | 1.4 | GO:0006452 | translational frameshifting(GO:0006452) positive regulation of translational elongation(GO:0045901) positive regulation of translational termination(GO:0045905) |
| 0.2 | 1.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
| 0.2 | 0.4 | GO:0048311 | mitochondrion distribution(GO:0048311) |
| 0.2 | 0.5 | GO:0006188 | IMP biosynthetic process(GO:0006188) IMP metabolic process(GO:0046040) |
| 0.2 | 0.9 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
| 0.2 | 0.2 | GO:1902414 | protein localization to adherens junction(GO:0071896) protein localization to cell junction(GO:1902414) |
| 0.2 | 2.2 | GO:0016925 | protein sumoylation(GO:0016925) |
| 0.2 | 0.7 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
| 0.2 | 1.2 | GO:0032814 | regulation of natural killer cell activation(GO:0032814) |
| 0.2 | 7.4 | GO:0043484 | regulation of RNA splicing(GO:0043484) |
| 0.2 | 1.2 | GO:0001756 | somitogenesis(GO:0001756) segmentation(GO:0035282) somite development(GO:0061053) |
| 0.2 | 0.2 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) negative regulation of membrane depolarization(GO:1904180) |
| 0.2 | 0.3 | GO:0090005 | negative regulation of establishment of protein localization to plasma membrane(GO:0090005) negative regulation of protein localization to plasma membrane(GO:1903077) negative regulation of protein localization to cell periphery(GO:1904376) |
| 0.2 | 1.0 | GO:0048703 | embryonic viscerocranium morphogenesis(GO:0048703) |
| 0.2 | 1.0 | GO:0006545 | glycine biosynthetic process(GO:0006545) |
| 0.2 | 0.3 | GO:0007206 | phospholipase C-activating G-protein coupled glutamate receptor signaling pathway(GO:0007206) |
| 0.2 | 1.0 | GO:0006002 | fructose 6-phosphate metabolic process(GO:0006002) |
| 0.2 | 3.2 | GO:0006110 | regulation of glycolytic process(GO:0006110) regulation of nucleoside metabolic process(GO:0009118) regulation of ATP metabolic process(GO:1903578) |
| 0.2 | 1.3 | GO:0043982 | histone H4-K5 acetylation(GO:0043981) histone H4-K8 acetylation(GO:0043982) |
| 0.2 | 0.8 | GO:0009235 | cobalamin metabolic process(GO:0009235) |
| 0.2 | 1.0 | GO:0043029 | T cell homeostasis(GO:0043029) |
| 0.2 | 1.5 | GO:0016558 | protein import into peroxisome matrix(GO:0016558) intracellular protein transmembrane import(GO:0044743) |
| 0.2 | 1.5 | GO:0034260 | negative regulation of GTPase activity(GO:0034260) |
| 0.2 | 1.0 | GO:0042635 | positive regulation of hair cycle(GO:0042635) positive regulation of hair follicle development(GO:0051798) |
| 0.2 | 1.2 | GO:0015671 | oxygen transport(GO:0015671) |
| 0.2 | 3.0 | GO:0043968 | histone H2A acetylation(GO:0043968) |
| 0.2 | 2.1 | GO:0045197 | establishment or maintenance of epithelial cell apical/basal polarity(GO:0045197) |
| 0.2 | 1.3 | GO:1901663 | quinone biosynthetic process(GO:1901663) |
| 0.2 | 1.0 | GO:0006772 | thiamine metabolic process(GO:0006772) |
| 0.2 | 0.3 | GO:0009135 | purine nucleoside diphosphate metabolic process(GO:0009135) purine ribonucleoside diphosphate metabolic process(GO:0009179) |
| 0.2 | 1.0 | GO:0046856 | phosphatidylinositol dephosphorylation(GO:0046856) |
| 0.2 | 7.4 | GO:0022900 | electron transport chain(GO:0022900) |
| 0.2 | 1.9 | GO:0030851 | granulocyte differentiation(GO:0030851) |
| 0.2 | 1.4 | GO:0006984 | ER-nucleus signaling pathway(GO:0006984) |
| 0.2 | 2.1 | GO:0006111 | regulation of gluconeogenesis(GO:0006111) |
| 0.2 | 0.3 | GO:0098534 | centriole replication(GO:0007099) centriole assembly(GO:0098534) |
| 0.2 | 0.5 | GO:0007549 | dosage compensation(GO:0007549) |
| 0.2 | 1.0 | GO:0032916 | transforming growth factor beta3 production(GO:0032907) regulation of transforming growth factor beta3 production(GO:0032910) positive regulation of transforming growth factor beta3 production(GO:0032916) |
| 0.2 | 0.2 | GO:0070528 | protein kinase C signaling(GO:0070528) |
| 0.2 | 2.7 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
| 0.2 | 2.5 | GO:0043496 | regulation of protein homodimerization activity(GO:0043496) |
| 0.2 | 1.9 | GO:0075713 | establishment of viral latency(GO:0019043) establishment of integrated proviral latency(GO:0075713) |
| 0.2 | 0.5 | GO:0030091 | protein repair(GO:0030091) |
| 0.2 | 0.3 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
| 0.2 | 0.8 | GO:0045730 | respiratory burst(GO:0045730) |
| 0.2 | 0.5 | GO:0003077 | obsolete negative regulation of diuresis(GO:0003077) |
| 0.2 | 9.1 | GO:0006096 | glycolytic process(GO:0006096) ATP generation from ADP(GO:0006757) |
| 0.2 | 0.6 | GO:0019348 | polyprenol metabolic process(GO:0016093) dolichol metabolic process(GO:0019348) |
| 0.2 | 0.2 | GO:0030948 | negative regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030948) |
| 0.2 | 1.2 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
| 0.2 | 1.4 | GO:0006975 | DNA damage induced protein phosphorylation(GO:0006975) |
| 0.2 | 0.3 | GO:0045896 | regulation of transcription during mitosis(GO:0045896) positive regulation of transcription during mitosis(GO:0045897) regulation of transcription from RNA polymerase II promoter, mitotic(GO:0046021) positive regulation of transcription from RNA polymerase II promoter during mitosis(GO:0046022) |
| 0.2 | 1.2 | GO:0035329 | hippo signaling(GO:0035329) |
| 0.2 | 0.6 | GO:0009103 | lipopolysaccharide biosynthetic process(GO:0009103) |
| 0.1 | 0.9 | GO:0032472 | cellular manganese ion homeostasis(GO:0030026) Golgi calcium ion homeostasis(GO:0032468) Golgi calcium ion transport(GO:0032472) manganese ion homeostasis(GO:0055071) |
| 0.1 | 0.9 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
| 0.1 | 0.4 | GO:0032776 | DNA methylation on cytosine(GO:0032776) C-5 methylation of cytosine(GO:0090116) |
| 0.1 | 0.7 | GO:0016265 | obsolete death(GO:0016265) |
| 0.1 | 0.4 | GO:0034498 | early endosome to Golgi transport(GO:0034498) |
| 0.1 | 2.8 | GO:0007158 | neuron cell-cell adhesion(GO:0007158) |
| 0.1 | 0.4 | GO:0048295 | positive regulation of isotype switching to IgE isotypes(GO:0048295) |
| 0.1 | 0.3 | GO:0031958 | corticosteroid receptor signaling pathway(GO:0031958) glucocorticoid receptor signaling pathway(GO:0042921) |
| 0.1 | 1.3 | GO:0070189 | kynurenine metabolic process(GO:0070189) |
| 0.1 | 15.0 | GO:0051028 | mRNA transport(GO:0051028) |
| 0.1 | 0.1 | GO:0051252 | regulation of RNA metabolic process(GO:0051252) |
| 0.1 | 1.9 | GO:0001919 | regulation of receptor recycling(GO:0001919) |
| 0.1 | 7.2 | GO:0006333 | chromatin assembly or disassembly(GO:0006333) |
| 0.1 | 1.0 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
| 0.1 | 0.7 | GO:0007090 | obsolete regulation of S phase of mitotic cell cycle(GO:0007090) |
| 0.1 | 0.7 | GO:0019388 | galactose catabolic process(GO:0019388) |
| 0.1 | 0.3 | GO:0006863 | purine nucleobase transport(GO:0006863) |
| 0.1 | 0.1 | GO:0031033 | myosin filament organization(GO:0031033) |
| 0.1 | 0.7 | GO:0018106 | peptidyl-histidine phosphorylation(GO:0018106) |
| 0.1 | 0.3 | GO:0006780 | uroporphyrinogen III biosynthetic process(GO:0006780) |
| 0.1 | 3.2 | GO:0051297 | microtubule organizing center organization(GO:0031023) centrosome organization(GO:0051297) |
| 0.1 | 2.5 | GO:0015949 | nucleobase-containing small molecule interconversion(GO:0015949) |
| 0.1 | 1.4 | GO:0006378 | mRNA polyadenylation(GO:0006378) |
| 0.1 | 0.4 | GO:0010759 | positive regulation of macrophage chemotaxis(GO:0010759) mononuclear cell migration(GO:0071674) regulation of mononuclear cell migration(GO:0071675) |
| 0.1 | 0.4 | GO:0006348 | chromatin silencing at telomere(GO:0006348) |
| 0.1 | 1.2 | GO:0002566 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
| 0.1 | 0.1 | GO:0030520 | intracellular estrogen receptor signaling pathway(GO:0030520) |
| 0.1 | 0.3 | GO:0002827 | positive regulation of T-helper 1 type immune response(GO:0002827) |
| 0.1 | 5.5 | GO:0042059 | negative regulation of epidermal growth factor receptor signaling pathway(GO:0042059) negative regulation of ERBB signaling pathway(GO:1901185) |
| 0.1 | 3.0 | GO:0006309 | DNA catabolic process, endonucleolytic(GO:0000737) apoptotic DNA fragmentation(GO:0006309) |
| 0.1 | 4.2 | GO:0070830 | bicellular tight junction assembly(GO:0070830) |
| 0.1 | 0.4 | GO:0006552 | leucine catabolic process(GO:0006552) |
| 0.1 | 4.4 | GO:0006302 | double-strand break repair(GO:0006302) |
| 0.1 | 2.8 | GO:0042113 | B cell activation(GO:0042113) |
| 0.1 | 1.1 | GO:0045885 | obsolete positive regulation of survival gene product expression(GO:0045885) |
| 0.1 | 0.1 | GO:0042693 | muscle cell fate commitment(GO:0042693) |
| 0.1 | 0.4 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
| 0.1 | 0.8 | GO:0006285 | base-excision repair, AP site formation(GO:0006285) |
| 0.1 | 0.3 | GO:0006434 | seryl-tRNA aminoacylation(GO:0006434) |
| 0.1 | 0.4 | GO:0070838 | divalent metal ion transport(GO:0070838) |
| 0.1 | 0.4 | GO:0010745 | negative regulation of macrophage derived foam cell differentiation(GO:0010745) |
| 0.1 | 2.5 | GO:0050832 | defense response to fungus(GO:0050832) |
| 0.1 | 0.6 | GO:0051480 | regulation of cytosolic calcium ion concentration(GO:0051480) |
| 0.1 | 0.5 | GO:0060013 | righting reflex(GO:0060013) |
| 0.1 | 0.9 | GO:1903078 | positive regulation of establishment of protein localization to plasma membrane(GO:0090004) positive regulation of protein localization to plasma membrane(GO:1903078) positive regulation of protein localization to cell periphery(GO:1904377) |
| 0.1 | 4.7 | GO:0016571 | histone methylation(GO:0016571) |
| 0.1 | 0.8 | GO:0015914 | phospholipid transport(GO:0015914) |
| 0.1 | 0.8 | GO:0060487 | lung cell differentiation(GO:0060479) lung epithelial cell differentiation(GO:0060487) |
| 0.1 | 1.5 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
| 0.1 | 0.5 | GO:0032291 | central nervous system myelination(GO:0022010) axon ensheathment in central nervous system(GO:0032291) |
| 0.1 | 1.1 | GO:0032411 | positive regulation of transporter activity(GO:0032411) |
| 0.1 | 0.1 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
| 0.1 | 3.6 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
| 0.1 | 1.7 | GO:0006898 | receptor-mediated endocytosis(GO:0006898) |
| 0.1 | 0.2 | GO:0043568 | positive regulation of insulin-like growth factor receptor signaling pathway(GO:0043568) |
| 0.1 | 2.0 | GO:0000084 | mitotic S phase(GO:0000084) |
| 0.1 | 0.1 | GO:0007128 | meiotic prophase I(GO:0007128) |
| 0.1 | 8.5 | GO:0065004 | protein-DNA complex assembly(GO:0065004) |
| 0.1 | 1.2 | GO:0043584 | nose development(GO:0043584) |
| 0.1 | 1.0 | GO:0048013 | ephrin receptor signaling pathway(GO:0048013) |
| 0.1 | 4.0 | GO:0071357 | response to type I interferon(GO:0034340) type I interferon signaling pathway(GO:0060337) cellular response to type I interferon(GO:0071357) |
| 0.1 | 1.1 | GO:0014823 | response to activity(GO:0014823) |
| 0.1 | 0.4 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
| 0.1 | 1.0 | GO:0045725 | positive regulation of glycogen biosynthetic process(GO:0045725) |
| 0.1 | 0.1 | GO:0009405 | pathogenesis(GO:0009405) |
| 0.1 | 0.4 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) chloride ion homeostasis(GO:0055064) |
| 0.1 | 0.4 | GO:0045601 | regulation of endothelial cell differentiation(GO:0045601) |
| 0.1 | 0.5 | GO:0045347 | negative regulation of MHC class II biosynthetic process(GO:0045347) |
| 0.1 | 0.6 | GO:0050684 | regulation of mRNA processing(GO:0050684) regulation of mRNA metabolic process(GO:1903311) |
| 0.1 | 0.3 | GO:0046477 | glycosylceramide catabolic process(GO:0046477) |
| 0.1 | 1.2 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
| 0.1 | 0.2 | GO:0071294 | cellular response to zinc ion(GO:0071294) |
| 0.1 | 0.9 | GO:0031648 | protein destabilization(GO:0031648) |
| 0.1 | 0.5 | GO:0045900 | negative regulation of translational elongation(GO:0045900) |
| 0.1 | 5.5 | GO:0006401 | RNA catabolic process(GO:0006401) |
| 0.1 | 0.5 | GO:0010225 | response to UV-C(GO:0010225) |
| 0.1 | 0.5 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
| 0.1 | 0.5 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
| 0.1 | 0.8 | GO:0046513 | ceramide biosynthetic process(GO:0046513) |
| 0.1 | 0.7 | GO:0021903 | rostrocaudal neural tube patterning(GO:0021903) |
| 0.1 | 0.9 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
| 0.1 | 0.9 | GO:0051438 | regulation of ubiquitin-protein transferase activity(GO:0051438) |
| 0.1 | 4.1 | GO:0015991 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
| 0.1 | 0.3 | GO:0030205 | dermatan sulfate metabolic process(GO:0030205) dermatan sulfate biosynthetic process(GO:0030208) |
| 0.1 | 0.8 | GO:0006477 | protein sulfation(GO:0006477) |
| 0.1 | 0.7 | GO:0043368 | positive T cell selection(GO:0043368) |
| 0.1 | 1.7 | GO:0001656 | metanephros development(GO:0001656) |
| 0.1 | 0.2 | GO:0071109 | superior temporal gyrus development(GO:0071109) |
| 0.1 | 6.7 | GO:0006892 | post-Golgi vesicle-mediated transport(GO:0006892) |
| 0.1 | 0.7 | GO:0007021 | tubulin complex assembly(GO:0007021) |
| 0.1 | 0.6 | GO:0060674 | placenta blood vessel development(GO:0060674) |
| 0.1 | 0.2 | GO:0048752 | semicircular canal morphogenesis(GO:0048752) |
| 0.1 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
| 0.1 | 4.8 | GO:0006310 | DNA recombination(GO:0006310) |
| 0.1 | 5.2 | GO:0016579 | protein deubiquitination(GO:0016579) protein modification by small protein removal(GO:0070646) |
| 0.1 | 2.6 | GO:0006289 | nucleotide-excision repair(GO:0006289) |
| 0.1 | 0.2 | GO:0031558 | obsolete induction of apoptosis in response to chemical stimulus(GO:0031558) |
| 0.1 | 0.1 | GO:0060729 | intestinal epithelial structure maintenance(GO:0060729) |
| 0.1 | 1.4 | GO:0002639 | positive regulation of immunoglobulin production(GO:0002639) |
| 0.1 | 0.2 | GO:0033522 | histone H2A ubiquitination(GO:0033522) |
| 0.1 | 1.5 | GO:0043124 | negative regulation of I-kappaB kinase/NF-kappaB signaling(GO:0043124) |
| 0.1 | 2.8 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
| 0.1 | 0.3 | GO:0003099 | positive regulation of the force of heart contraction by chemical signal(GO:0003099) |
| 0.1 | 0.3 | GO:0006166 | purine ribonucleoside salvage(GO:0006166) |
| 0.1 | 2.4 | GO:0030593 | neutrophil chemotaxis(GO:0030593) neutrophil migration(GO:1990266) |
| 0.1 | 0.2 | GO:0071542 | dopaminergic neuron differentiation(GO:0071542) |
| 0.1 | 0.3 | GO:0033578 | protein glycosylation in Golgi(GO:0033578) |
| 0.1 | 3.1 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
| 0.1 | 1.6 | GO:0001938 | positive regulation of endothelial cell proliferation(GO:0001938) |
| 0.1 | 0.3 | GO:0010430 | ethanol catabolic process(GO:0006068) fatty acid omega-oxidation(GO:0010430) |
| 0.1 | 0.9 | GO:0006353 | DNA-templated transcription, termination(GO:0006353) |
| 0.1 | 0.3 | GO:0006167 | AMP biosynthetic process(GO:0006167) |
| 0.1 | 0.3 | GO:0001992 | regulation of systemic arterial blood pressure by vasopressin(GO:0001992) |
| 0.1 | 0.5 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
| 0.1 | 19.1 | GO:0006397 | mRNA processing(GO:0006397) |
| 0.1 | 0.7 | GO:0060438 | trachea development(GO:0060438) |
| 0.1 | 1.6 | GO:0007052 | mitotic spindle organization(GO:0007052) |
| 0.1 | 0.5 | GO:0050931 | melanocyte differentiation(GO:0030318) pigment cell differentiation(GO:0050931) |
| 0.1 | 1.0 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
| 0.1 | 1.2 | GO:0021522 | spinal cord motor neuron differentiation(GO:0021522) |
| 0.1 | 0.2 | GO:0033962 | cytoplasmic mRNA processing body assembly(GO:0033962) |
| 0.1 | 0.5 | GO:0035455 | response to interferon-alpha(GO:0035455) |
| 0.1 | 7.2 | GO:0050851 | antigen receptor-mediated signaling pathway(GO:0050851) |
| 0.1 | 1.1 | GO:0045670 | regulation of osteoclast differentiation(GO:0045670) |
| 0.1 | 0.2 | GO:0031058 | positive regulation of histone modification(GO:0031058) |
| 0.1 | 0.8 | GO:0032836 | glomerular basement membrane development(GO:0032836) |
| 0.1 | 0.4 | GO:0034339 | obsolete regulation of transcription from RNA polymerase II promoter by nuclear hormone receptor(GO:0034339) |
| 0.1 | 0.2 | GO:0006655 | phosphatidylglycerol biosynthetic process(GO:0006655) cardiolipin metabolic process(GO:0032048) cardiolipin biosynthetic process(GO:0032049) phosphatidylglycerol metabolic process(GO:0046471) |
| 0.1 | 0.5 | GO:0008089 | anterograde axonal transport(GO:0008089) axonal transport(GO:0098930) |
| 0.1 | 1.3 | GO:0000079 | regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0000079) regulation of cyclin-dependent protein kinase activity(GO:1904029) |
| 0.1 | 5.4 | GO:0006968 | cellular defense response(GO:0006968) |
| 0.1 | 1.1 | GO:0016071 | mRNA metabolic process(GO:0016071) |
| 0.1 | 0.1 | GO:0030320 | cellular anion homeostasis(GO:0030002) cellular monovalent inorganic anion homeostasis(GO:0030320) |
| 0.1 | 1.3 | GO:0015939 | pantothenate metabolic process(GO:0015939) |
| 0.1 | 0.2 | GO:0071680 | response to indole-3-methanol(GO:0071680) cellular response to indole-3-methanol(GO:0071681) |
| 0.1 | 0.7 | GO:0046902 | regulation of mitochondrial membrane permeability(GO:0046902) regulation of membrane permeability(GO:0090559) |
| 0.1 | 0.5 | GO:0001946 | lymphangiogenesis(GO:0001946) lymph vessel morphogenesis(GO:0036303) |
| 0.1 | 6.8 | GO:0000209 | protein polyubiquitination(GO:0000209) |
| 0.1 | 5.9 | GO:0006281 | DNA repair(GO:0006281) |
| 0.1 | 0.8 | GO:0070327 | thyroid hormone transport(GO:0070327) |
| 0.1 | 0.3 | GO:0010628 | positive regulation of gene expression(GO:0010628) |
| 0.1 | 0.9 | GO:0046037 | GMP metabolic process(GO:0046037) |
| 0.1 | 0.3 | GO:0030261 | chromosome condensation(GO:0030261) |
| 0.1 | 0.1 | GO:0007412 | axon target recognition(GO:0007412) |
| 0.1 | 0.3 | GO:0043163 | cell envelope organization(GO:0043163) external encapsulating structure organization(GO:0045229) |
| 0.1 | 0.1 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
| 0.1 | 0.9 | GO:0048015 | phosphatidylinositol-mediated signaling(GO:0048015) inositol lipid-mediated signaling(GO:0048017) |
| 0.1 | 0.2 | GO:0006428 | isoleucyl-tRNA aminoacylation(GO:0006428) |
| 0.1 | 0.4 | GO:0007140 | male meiosis(GO:0007140) |
| 0.1 | 0.3 | GO:0047496 | vesicle transport along microtubule(GO:0047496) vesicle cytoskeletal trafficking(GO:0099518) |
| 0.1 | 0.2 | GO:0009129 | pyrimidine nucleoside monophosphate metabolic process(GO:0009129) |
| 0.1 | 0.2 | GO:1903301 | regulation of glucokinase activity(GO:0033131) positive regulation of glucokinase activity(GO:0033133) regulation of hexokinase activity(GO:1903299) positive regulation of hexokinase activity(GO:1903301) |
| 0.1 | 0.2 | GO:0006106 | fumarate metabolic process(GO:0006106) |
| 0.1 | 0.2 | GO:0048075 | positive regulation of eye pigmentation(GO:0048075) |
| 0.1 | 0.1 | GO:0070849 | response to epidermal growth factor(GO:0070849) |
| 0.1 | 1.4 | GO:0006974 | cellular response to DNA damage stimulus(GO:0006974) |
| 0.1 | 0.1 | GO:0045213 | neurotransmitter receptor metabolic process(GO:0045213) |
| 0.1 | 0.2 | GO:0050982 | detection of mechanical stimulus(GO:0050982) |
| 0.1 | 0.2 | GO:0030578 | nuclear body organization(GO:0030575) PML body organization(GO:0030578) |
| 0.1 | 1.4 | GO:0007032 | endosome organization(GO:0007032) |
| 0.1 | 0.1 | GO:0071359 | cellular response to dsRNA(GO:0071359) |
| 0.1 | 0.5 | GO:0000188 | inactivation of MAPK activity(GO:0000188) |
| 0.1 | 0.2 | GO:0046885 | positive regulation of hormone metabolic process(GO:0032352) regulation of hormone biosynthetic process(GO:0046885) positive regulation of hormone biosynthetic process(GO:0046886) |
| 0.1 | 0.3 | GO:0030225 | macrophage differentiation(GO:0030225) |
| 0.1 | 0.9 | GO:0043616 | keratinocyte proliferation(GO:0043616) |
| 0.1 | 1.0 | GO:0006783 | heme biosynthetic process(GO:0006783) |
| 0.1 | 0.3 | GO:0008216 | spermidine metabolic process(GO:0008216) |
| 0.1 | 1.8 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
| 0.1 | 0.1 | GO:0015838 | amino-acid betaine transport(GO:0015838) carnitine transport(GO:0015879) |
| 0.1 | 0.2 | GO:0071474 | cellular water homeostasis(GO:0009992) cellular hyperosmotic response(GO:0071474) |
| 0.1 | 0.1 | GO:0043162 | ubiquitin-dependent protein catabolic process via the multivesicular body sorting pathway(GO:0043162) |
| 0.1 | 0.2 | GO:0061099 | negative regulation of protein tyrosine kinase activity(GO:0061099) |
| 0.1 | 0.2 | GO:0002200 | somatic diversification of immune receptors(GO:0002200) |
| 0.1 | 0.1 | GO:0032099 | negative regulation of appetite(GO:0032099) |
| 0.1 | 1.3 | GO:0006220 | pyrimidine nucleotide metabolic process(GO:0006220) |
| 0.1 | 0.6 | GO:0045839 | negative regulation of mitotic nuclear division(GO:0045839) |
| 0.1 | 0.4 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
| 0.1 | 0.2 | GO:0046340 | diacylglycerol catabolic process(GO:0046340) |
| 0.1 | 0.1 | GO:1902600 | hydrogen ion transmembrane transport(GO:1902600) |
| 0.1 | 0.1 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
| 0.1 | 0.3 | GO:0018343 | protein farnesylation(GO:0018343) |
| 0.1 | 0.1 | GO:0030828 | positive regulation of cGMP biosynthetic process(GO:0030828) |
| 0.1 | 0.2 | GO:0018243 | protein O-linked glycosylation via serine(GO:0018242) protein O-linked glycosylation via threonine(GO:0018243) |
| 0.1 | 0.6 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
| 0.1 | 0.2 | GO:0000114 | obsolete regulation of transcription involved in G1 phase of mitotic cell cycle(GO:0000114) |
| 0.1 | 0.5 | GO:0007219 | Notch signaling pathway(GO:0007219) |
| 0.1 | 0.1 | GO:0042986 | positive regulation of amyloid precursor protein biosynthetic process(GO:0042986) |
| 0.1 | 0.1 | GO:0000239 | pachytene(GO:0000239) |
| 0.1 | 0.4 | GO:0050880 | regulation of tube size(GO:0035150) regulation of blood vessel size(GO:0050880) |
| 0.1 | 0.3 | GO:0035019 | somatic stem cell population maintenance(GO:0035019) |
| 0.1 | 1.0 | GO:0008299 | isoprenoid biosynthetic process(GO:0008299) |
| 0.1 | 0.4 | GO:0030308 | negative regulation of cell growth(GO:0030308) |
| 0.1 | 0.4 | GO:0043065 | positive regulation of apoptotic process(GO:0043065) |
| 0.1 | 0.7 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
| 0.1 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
| 0.1 | 0.1 | GO:0014887 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
| 0.1 | 1.3 | GO:0006338 | chromatin remodeling(GO:0006338) |
| 0.1 | 0.3 | GO:0033523 | histone H2B ubiquitination(GO:0033523) |
| 0.1 | 0.2 | GO:0009082 | branched-chain amino acid biosynthetic process(GO:0009082) |
| 0.1 | 0.1 | GO:0031115 | negative regulation of microtubule polymerization(GO:0031115) |
| 0.1 | 0.2 | GO:0031649 | heat generation(GO:0031649) |
| 0.1 | 0.1 | GO:0002428 | antigen processing and presentation of peptide antigen via MHC class Ib(GO:0002428) antigen processing and presentation of exogenous peptide antigen via MHC class Ib(GO:0002477) antigen processing and presentation of exogenous protein antigen via MHC class Ib, TAP-dependent(GO:0002481) cytosol to ER transport(GO:0046967) |
| 0.1 | 0.1 | GO:0001507 | acetylcholine catabolic process in synaptic cleft(GO:0001507) acetylcholine catabolic process(GO:0006581) |
| 0.1 | 0.2 | GO:0007288 | sperm axoneme assembly(GO:0007288) |
| 0.1 | 0.5 | GO:0006903 | vesicle targeting(GO:0006903) |
| 0.1 | 2.3 | GO:0007605 | sensory perception of sound(GO:0007605) |
| 0.1 | 0.1 | GO:0009698 | phenylpropanoid metabolic process(GO:0009698) coumarin metabolic process(GO:0009804) |
| 0.1 | 0.1 | GO:0002089 | lens morphogenesis in camera-type eye(GO:0002089) |
| 0.1 | 0.1 | GO:0010830 | regulation of myotube differentiation(GO:0010830) positive regulation of myotube differentiation(GO:0010831) regulation of striated muscle cell differentiation(GO:0051153) positive regulation of striated muscle cell differentiation(GO:0051155) |
| 0.1 | 0.1 | GO:0090218 | regulation of phosphatidylinositol 3-kinase activity(GO:0043551) positive regulation of lipid kinase activity(GO:0090218) |
| 0.1 | 0.1 | GO:0014053 | negative regulation of gamma-aminobutyric acid secretion(GO:0014053) |
| 0.1 | 2.3 | GO:0016458 | gene silencing(GO:0016458) |
| 0.1 | 0.3 | GO:0001974 | blood vessel remodeling(GO:0001974) |
| 0.1 | 0.6 | GO:0060512 | prostate gland morphogenesis(GO:0060512) |
| 0.1 | 0.6 | GO:0009086 | methionine biosynthetic process(GO:0009086) |
| 0.1 | 0.4 | GO:0031444 | slow-twitch skeletal muscle fiber contraction(GO:0031444) |
| 0.1 | 0.5 | GO:0009083 | branched-chain amino acid catabolic process(GO:0009083) |
| 0.1 | 0.5 | GO:0009755 | hormone-mediated signaling pathway(GO:0009755) |
| 0.1 | 0.7 | GO:0051289 | protein homotetramerization(GO:0051289) |
| 0.1 | 0.3 | GO:0060749 | mammary gland alveolus development(GO:0060749) mammary gland lobule development(GO:0061377) |
| 0.1 | 0.5 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
| 0.1 | 0.5 | GO:0035587 | purinergic receptor signaling pathway(GO:0035587) purinergic nucleotide receptor signaling pathway(GO:0035590) |
| 0.1 | 0.8 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
| 0.1 | 0.2 | GO:0001831 | trophectodermal cellular morphogenesis(GO:0001831) |
| 0.1 | 0.5 | GO:0051168 | nuclear export(GO:0051168) |
| 0.1 | 0.8 | GO:0006826 | iron ion transport(GO:0006826) |
| 0.1 | 0.3 | GO:0032464 | positive regulation of protein oligomerization(GO:0032461) positive regulation of protein homooligomerization(GO:0032464) |
| 0.1 | 0.2 | GO:0016322 | neuron remodeling(GO:0016322) |
| 0.1 | 0.3 | GO:0006270 | DNA replication initiation(GO:0006270) |
| 0.1 | 0.2 | GO:0051552 | flavone metabolic process(GO:0051552) |
| 0.0 | 1.3 | GO:0031424 | keratinization(GO:0031424) |
| 0.0 | 0.1 | GO:0032926 | negative regulation of activin receptor signaling pathway(GO:0032926) |
| 0.0 | 0.3 | GO:2000124 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) regulation of endocannabinoid signaling pathway(GO:2000124) |
| 0.0 | 0.2 | GO:0021506 | anterior neuropore closure(GO:0021506) neuropore closure(GO:0021995) |
| 0.0 | 2.4 | GO:0005977 | glycogen metabolic process(GO:0005977) |
| 0.0 | 0.2 | GO:0032438 | melanosome organization(GO:0032438) pigment granule organization(GO:0048753) |
| 0.0 | 0.5 | GO:0009070 | serine family amino acid biosynthetic process(GO:0009070) |
| 0.0 | 0.2 | GO:0002430 | complement receptor mediated signaling pathway(GO:0002430) |
| 0.0 | 0.1 | GO:0042345 | regulation of NF-kappaB import into nucleus(GO:0042345) NF-kappaB import into nucleus(GO:0042348) |
| 0.0 | 0.3 | GO:0008631 | intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0008631) cell death in response to oxidative stress(GO:0036473) |
| 0.0 | 0.1 | GO:0050766 | positive regulation of phagocytosis(GO:0050766) |
| 0.0 | 0.1 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
| 0.0 | 0.4 | GO:0046676 | negative regulation of peptide secretion(GO:0002792) negative regulation of insulin secretion(GO:0046676) negative regulation of peptide hormone secretion(GO:0090278) |
| 0.0 | 0.5 | GO:0070482 | response to oxygen levels(GO:0070482) |
| 0.0 | 0.3 | GO:0007494 | midgut development(GO:0007494) |
| 0.0 | 0.8 | GO:0019370 | leukotriene biosynthetic process(GO:0019370) |
| 0.0 | 0.3 | GO:0043415 | positive regulation of skeletal muscle tissue regeneration(GO:0043415) regulation of skeletal muscle tissue regeneration(GO:0043416) |
| 0.0 | 0.3 | GO:0015781 | pyrimidine nucleotide-sugar transport(GO:0015781) |
| 0.0 | 0.2 | GO:0051646 | mitochondrion localization(GO:0051646) |
| 0.0 | 0.6 | GO:0042438 | melanin biosynthetic process(GO:0042438) |
| 0.0 | 0.2 | GO:0090399 | replicative senescence(GO:0090399) |
| 0.0 | 0.6 | GO:0032456 | endocytic recycling(GO:0032456) |
| 0.0 | 0.5 | GO:0006004 | fucose metabolic process(GO:0006004) |
| 0.0 | 0.8 | GO:0046329 | negative regulation of JNK cascade(GO:0046329) |
| 0.0 | 0.6 | GO:0045637 | regulation of myeloid cell differentiation(GO:0045637) |
| 0.0 | 0.2 | GO:0045786 | negative regulation of cell cycle(GO:0045786) |
| 0.0 | 0.1 | GO:0001658 | branching involved in ureteric bud morphogenesis(GO:0001658) |
| 0.0 | 0.1 | GO:0099515 | nuclear migration along microfilament(GO:0031022) actin filament-based transport(GO:0099515) |
| 0.0 | 0.2 | GO:0002088 | lens development in camera-type eye(GO:0002088) |
| 0.0 | 1.0 | GO:0007189 | adenylate cyclase-activating G-protein coupled receptor signaling pathway(GO:0007189) |
| 0.0 | 0.6 | GO:0040014 | regulation of multicellular organism growth(GO:0040014) |
| 0.0 | 0.4 | GO:0015992 | proton transport(GO:0015992) |
| 0.0 | 0.2 | GO:0007616 | long-term memory(GO:0007616) |
| 0.0 | 0.4 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
| 0.0 | 0.6 | GO:0008210 | estrogen metabolic process(GO:0008210) |
| 0.0 | 0.1 | GO:0048147 | negative regulation of fibroblast proliferation(GO:0048147) |
| 0.0 | 0.1 | GO:0035608 | protein deglutamylation(GO:0035608) |
| 0.0 | 0.3 | GO:0043526 | obsolete neuroprotection(GO:0043526) |
| 0.0 | 0.5 | GO:0042596 | fear response(GO:0042596) |
| 0.0 | 0.2 | GO:0001906 | cell killing(GO:0001906) |
| 0.0 | 0.6 | GO:0034138 | toll-like receptor 3 signaling pathway(GO:0034138) |
| 0.0 | 0.2 | GO:0007635 | chemosensory behavior(GO:0007635) |
| 0.0 | 0.7 | GO:0045980 | negative regulation of nucleotide metabolic process(GO:0045980) |
| 0.0 | 0.1 | GO:0048627 | myoblast development(GO:0048627) |
| 0.0 | 0.1 | GO:1901142 | insulin processing(GO:0030070) insulin metabolic process(GO:1901142) |
| 0.0 | 4.8 | GO:0006813 | potassium ion transport(GO:0006813) |
| 0.0 | 0.2 | GO:0048536 | spleen development(GO:0048536) |
| 0.0 | 0.1 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
| 0.0 | 0.0 | GO:0060972 | left/right pattern formation(GO:0060972) |
| 0.0 | 0.1 | GO:0042637 | catagen(GO:0042637) |
| 0.0 | 0.8 | GO:0007163 | establishment or maintenance of cell polarity(GO:0007163) |
| 0.0 | 0.1 | GO:0021781 | glial cell fate commitment(GO:0021781) |
| 0.0 | 0.2 | GO:0048169 | regulation of long-term neuronal synaptic plasticity(GO:0048169) |
| 0.0 | 0.1 | GO:0034755 | iron ion transmembrane transport(GO:0034755) |
| 0.0 | 2.2 | GO:0007608 | sensory perception of smell(GO:0007608) |
| 0.0 | 0.1 | GO:0042538 | hyperosmotic salinity response(GO:0042538) |
| 0.0 | 0.9 | GO:0006399 | tRNA metabolic process(GO:0006399) |
| 0.0 | 0.3 | GO:0016226 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
| 0.0 | 0.1 | GO:0007285 | primary spermatocyte growth(GO:0007285) |
| 0.0 | 0.6 | GO:0007498 | mesoderm development(GO:0007498) |
| 0.0 | 0.1 | GO:0030252 | growth hormone secretion(GO:0030252) |
| 0.0 | 0.4 | GO:0045732 | positive regulation of protein catabolic process(GO:0045732) |
| 0.0 | 0.2 | GO:0006636 | unsaturated fatty acid biosynthetic process(GO:0006636) |
| 0.0 | 0.7 | GO:0043966 | histone H3 acetylation(GO:0043966) |
| 0.0 | 0.1 | GO:0045165 | cell fate commitment(GO:0045165) |
| 0.0 | 0.3 | GO:0031396 | regulation of protein ubiquitination(GO:0031396) |
| 0.0 | 0.1 | GO:0007258 | JUN phosphorylation(GO:0007258) |
| 0.0 | 0.1 | GO:0060644 | mammary gland epithelial cell differentiation(GO:0060644) |
| 0.0 | 0.4 | GO:0001709 | cell fate determination(GO:0001709) |
| 0.0 | 0.8 | GO:0007270 | neuron-neuron synaptic transmission(GO:0007270) |
| 0.0 | 0.4 | GO:0007212 | dopamine receptor signaling pathway(GO:0007212) |
| 0.0 | 0.5 | GO:0008380 | RNA splicing(GO:0008380) |
| 0.0 | 0.1 | GO:0032891 | negative regulation of organic acid transport(GO:0032891) |
| 0.0 | 0.1 | GO:0051262 | protein tetramerization(GO:0051262) |
| 0.0 | 6.4 | GO:0006412 | translation(GO:0006412) |
| 0.0 | 0.1 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
| 0.0 | 0.1 | GO:0051785 | positive regulation of mitotic nuclear division(GO:0045840) positive regulation of nuclear division(GO:0051785) |
| 0.0 | 0.1 | GO:0002832 | negative regulation of response to biotic stimulus(GO:0002832) |
| 0.0 | 0.2 | GO:0045987 | positive regulation of smooth muscle contraction(GO:0045987) |
| 0.0 | 0.2 | GO:0001893 | maternal placenta development(GO:0001893) |
| 0.0 | 1.3 | GO:0009156 | ribonucleoside monophosphate biosynthetic process(GO:0009156) |
| 0.0 | 0.3 | GO:0046320 | regulation of fatty acid oxidation(GO:0046320) |
| 0.0 | 0.1 | GO:0008542 | visual learning(GO:0008542) |
| 0.0 | 0.1 | GO:0030539 | male genitalia development(GO:0030539) |
| 0.0 | 2.9 | GO:0044419 | interspecies interaction between organisms(GO:0044419) |
| 0.0 | 36.4 | GO:0006351 | transcription, DNA-templated(GO:0006351) nucleic acid-templated transcription(GO:0097659) |
| 0.0 | 0.2 | GO:0010923 | negative regulation of phosphatase activity(GO:0010923) negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
| 0.0 | 0.2 | GO:0007172 | signal complex assembly(GO:0007172) |
| 0.0 | 0.4 | GO:0007214 | gamma-aminobutyric acid signaling pathway(GO:0007214) |
| 0.0 | 0.4 | GO:0048839 | inner ear development(GO:0048839) |
| 0.0 | 9.9 | GO:0006955 | immune response(GO:0006955) |
| 0.0 | 0.1 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
| 0.0 | 0.1 | GO:0045047 | protein targeting to ER(GO:0045047) establishment of protein localization to endoplasmic reticulum(GO:0072599) |
| 0.0 | 0.1 | GO:0009261 | purine ribonucleotide catabolic process(GO:0009154) ribonucleotide catabolic process(GO:0009261) |
| 0.0 | 0.1 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
| 0.0 | 0.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
| 0.0 | 0.1 | GO:0033574 | response to testosterone(GO:0033574) |
| 0.0 | 0.3 | GO:0046330 | positive regulation of JNK cascade(GO:0046330) |
| 0.0 | 1.8 | GO:0016567 | protein ubiquitination(GO:0016567) |
| 0.0 | 0.1 | GO:0042335 | cuticle development(GO:0042335) |
| 0.0 | 0.1 | GO:0007266 | Rho protein signal transduction(GO:0007266) |
| 0.0 | 0.1 | GO:0030838 | positive regulation of actin filament polymerization(GO:0030838) |
| 0.0 | 0.3 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
| 0.0 | 0.1 | GO:0006669 | sphinganine-1-phosphate biosynthetic process(GO:0006669) |
| 0.0 | 0.2 | GO:0009583 | phototransduction(GO:0007602) detection of light stimulus(GO:0009583) |
| 0.0 | 0.3 | GO:0030574 | collagen catabolic process(GO:0030574) |
| 0.0 | 0.1 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
| 0.0 | 0.1 | GO:0006542 | glutamine biosynthetic process(GO:0006542) |
| 0.0 | 0.1 | GO:0071230 | cellular response to amino acid stimulus(GO:0071230) |
| 0.0 | 0.1 | GO:0048009 | insulin-like growth factor receptor signaling pathway(GO:0048009) |
| 0.0 | 0.1 | GO:0032612 | interleukin-1 production(GO:0032612) |
| 0.0 | 0.3 | GO:0071577 | zinc II ion transmembrane transport(GO:0071577) |
| 0.0 | 0.1 | GO:0015937 | coenzyme A biosynthetic process(GO:0015937) |
| 0.0 | 0.0 | GO:0010675 | regulation of cellular carbohydrate metabolic process(GO:0010675) |
| 0.0 | 0.1 | GO:0032963 | collagen metabolic process(GO:0032963) |
| 0.0 | 0.0 | GO:0043171 | peptide catabolic process(GO:0043171) |
| 0.0 | 0.0 | GO:0006538 | glutamate catabolic process(GO:0006538) |
| 0.0 | 0.6 | GO:0051084 | 'de novo' posttranslational protein folding(GO:0051084) |
| 0.0 | 0.0 | GO:0007623 | circadian rhythm(GO:0007623) |
| 0.0 | 0.1 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
| 0.0 | 0.3 | GO:0046777 | protein autophosphorylation(GO:0046777) |
| 0.0 | 0.2 | GO:0006596 | polyamine biosynthetic process(GO:0006596) cellular biogenic amine biosynthetic process(GO:0042401) |
| 0.0 | 0.3 | GO:0015804 | neutral amino acid transport(GO:0015804) |
| 0.0 | 0.1 | GO:0002021 | response to dietary excess(GO:0002021) |
| 0.0 | 0.1 | GO:0007631 | feeding behavior(GO:0007631) |
| 0.0 | 0.0 | GO:0043949 | regulation of cAMP-mediated signaling(GO:0043949) |
| 0.0 | 0.0 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
| 0.0 | 0.0 | GO:1901224 | activation of NF-kappaB-inducing kinase activity(GO:0007250) NIK/NF-kappaB signaling(GO:0038061) regulation of NIK/NF-kappaB signaling(GO:1901222) positive regulation of NIK/NF-kappaB signaling(GO:1901224) |
| 0.0 | 0.1 | GO:0046887 | positive regulation of hormone secretion(GO:0046887) |
| 0.0 | 0.1 | GO:0018101 | protein citrullination(GO:0018101) citrulline biosynthetic process(GO:0019240) |
| 0.0 | 0.2 | GO:0016079 | synaptic vesicle exocytosis(GO:0016079) |
| 0.0 | 0.1 | GO:0007567 | parturition(GO:0007567) |
| 0.0 | 0.1 | GO:0048268 | clathrin coat assembly(GO:0048268) |
Gene overrepresentation in cellular_component category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.4 | 7.3 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
| 2.2 | 6.6 | GO:0071001 | U4/U6 snRNP(GO:0071001) |
| 2.1 | 6.4 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
| 1.9 | 7.5 | GO:0000800 | lateral element(GO:0000800) |
| 1.7 | 10.0 | GO:0019815 | immunoglobulin complex(GO:0019814) B cell receptor complex(GO:0019815) |
| 1.6 | 8.0 | GO:0032807 | DNA ligase IV complex(GO:0032807) |
| 1.2 | 24.9 | GO:0042613 | MHC class II protein complex(GO:0042613) |
| 1.1 | 3.4 | GO:0031372 | UBC13-MMS2 complex(GO:0031372) |
| 1.1 | 3.4 | GO:0000806 | Y chromosome(GO:0000806) |
| 1.1 | 3.4 | GO:0032009 | early phagosome(GO:0032009) |
| 1.0 | 9.4 | GO:0030681 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
| 1.0 | 3.1 | GO:0030904 | retromer complex(GO:0030904) |
| 1.0 | 1.0 | GO:0030895 | apolipoprotein B mRNA editing enzyme complex(GO:0030895) |
| 0.9 | 11.3 | GO:0005885 | Arp2/3 protein complex(GO:0005885) |
| 0.8 | 5.9 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
| 0.8 | 5.0 | GO:0072357 | PTW/PP1 phosphatase complex(GO:0072357) |
| 0.8 | 7.4 | GO:0005662 | DNA replication factor A complex(GO:0005662) |
| 0.8 | 10.6 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
| 0.8 | 5.7 | GO:0030870 | Mre11 complex(GO:0030870) |
| 0.8 | 3.2 | GO:0033269 | internode region of axon(GO:0033269) |
| 0.8 | 5.5 | GO:0001891 | phagocytic cup(GO:0001891) |
| 0.8 | 3.8 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
| 0.7 | 2.9 | GO:0033202 | Ino80 complex(GO:0031011) DNA helicase complex(GO:0033202) INO80-type complex(GO:0097346) |
| 0.7 | 2.2 | GO:0005850 | eukaryotic translation initiation factor 2 complex(GO:0005850) |
| 0.7 | 8.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
| 0.7 | 2.9 | GO:0000164 | protein phosphatase type 1 complex(GO:0000164) |
| 0.7 | 2.8 | GO:0031436 | BRCA1-BARD1 complex(GO:0031436) |
| 0.7 | 6.2 | GO:0000796 | condensin complex(GO:0000796) |
| 0.7 | 6.1 | GO:0016272 | prefoldin complex(GO:0016272) |
| 0.7 | 2.7 | GO:0032777 | Piccolo NuA4 histone acetyltransferase complex(GO:0032777) |
| 0.7 | 2.0 | GO:0005686 | U2 snRNP(GO:0005686) |
| 0.7 | 6.1 | GO:0042555 | MCM complex(GO:0042555) |
| 0.7 | 2.0 | GO:0005674 | transcription factor TFIIF complex(GO:0005674) |
| 0.7 | 4.0 | GO:0005945 | 6-phosphofructokinase complex(GO:0005945) |
| 0.6 | 9.0 | GO:0005838 | proteasome regulatory particle(GO:0005838) |
| 0.6 | 7.0 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
| 0.6 | 2.6 | GO:0005687 | U4 snRNP(GO:0005687) |
| 0.6 | 6.7 | GO:0032039 | integrator complex(GO:0032039) |
| 0.6 | 13.1 | GO:0005852 | eukaryotic translation initiation factor 3 complex(GO:0005852) |
| 0.6 | 2.4 | GO:0070545 | PeBoW complex(GO:0070545) |
| 0.6 | 7.1 | GO:0031254 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
| 0.6 | 4.1 | GO:0005744 | mitochondrial inner membrane presequence translocase complex(GO:0005744) |
| 0.6 | 4.1 | GO:0019907 | cyclin-dependent protein kinase activating kinase holoenzyme complex(GO:0019907) |
| 0.6 | 2.9 | GO:0032133 | chromosome passenger complex(GO:0032133) |
| 0.6 | 1.7 | GO:0071986 | Ragulator complex(GO:0071986) |
| 0.6 | 5.6 | GO:0005766 | primary lysosome(GO:0005766) azurophil granule(GO:0042582) |
| 0.6 | 2.2 | GO:0030893 | meiotic cohesin complex(GO:0030893) |
| 0.6 | 24.2 | GO:0005761 | organellar ribosome(GO:0000313) mitochondrial ribosome(GO:0005761) |
| 0.5 | 5.4 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
| 0.5 | 1.6 | GO:0031262 | Ndc80 complex(GO:0031262) |
| 0.5 | 4.2 | GO:0042719 | mitochondrial intermembrane space protein transporter complex(GO:0042719) |
| 0.5 | 0.5 | GO:0005828 | kinetochore microtubule(GO:0005828) |
| 0.5 | 1.5 | GO:0000439 | core TFIIH complex(GO:0000439) |
| 0.5 | 6.7 | GO:0005732 | small nucleolar ribonucleoprotein complex(GO:0005732) |
| 0.5 | 7.1 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
| 0.5 | 1.9 | GO:0045257 | mitochondrial respiratory chain complex II, succinate dehydrogenase complex (ubiquinone)(GO:0005749) succinate dehydrogenase complex (ubiquinone)(GO:0045257) respiratory chain complex II(GO:0045273) succinate dehydrogenase complex(GO:0045281) fumarate reductase complex(GO:0045283) |
| 0.5 | 1.8 | GO:0005672 | transcription factor TFIIA complex(GO:0005672) |
| 0.5 | 0.9 | GO:0030132 | clathrin coat of coated pit(GO:0030132) |
| 0.5 | 1.8 | GO:0070761 | pre-snoRNP complex(GO:0070761) |
| 0.4 | 2.2 | GO:0001741 | XY body(GO:0001741) |
| 0.4 | 1.7 | GO:0016600 | flotillin complex(GO:0016600) |
| 0.4 | 4.6 | GO:0016442 | RISC complex(GO:0016442) RNAi effector complex(GO:0031332) |
| 0.4 | 0.8 | GO:0000145 | exocyst(GO:0000145) |
| 0.4 | 1.2 | GO:0030981 | cortical microtubule cytoskeleton(GO:0030981) |
| 0.4 | 0.8 | GO:0005688 | U6 snRNP(GO:0005688) |
| 0.4 | 0.4 | GO:0000214 | tRNA-intron endonuclease complex(GO:0000214) |
| 0.4 | 3.8 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
| 0.4 | 1.1 | GO:0070937 | CRD-mediated mRNA stability complex(GO:0070937) |
| 0.4 | 7.8 | GO:0035267 | NuA4 histone acetyltransferase complex(GO:0035267) |
| 0.4 | 1.9 | GO:0000444 | MIS12/MIND type complex(GO:0000444) |
| 0.4 | 1.5 | GO:0000125 | PCAF complex(GO:0000125) |
| 0.4 | 8.4 | GO:0005665 | DNA-directed RNA polymerase II, core complex(GO:0005665) |
| 0.4 | 2.6 | GO:0030121 | AP-1 adaptor complex(GO:0030121) |
| 0.4 | 3.6 | GO:0001673 | male germ cell nucleus(GO:0001673) |
| 0.4 | 2.1 | GO:0005667 | transcription factor complex(GO:0005667) |
| 0.4 | 16.6 | GO:0042645 | mitochondrial nucleoid(GO:0042645) |
| 0.4 | 1.8 | GO:0005847 | mRNA cleavage and polyadenylation specificity factor complex(GO:0005847) |
| 0.3 | 5.6 | GO:0031080 | nuclear pore outer ring(GO:0031080) |
| 0.3 | 1.7 | GO:0017101 | aminoacyl-tRNA synthetase multienzyme complex(GO:0017101) |
| 0.3 | 0.3 | GO:0001652 | granular component(GO:0001652) |
| 0.3 | 2.6 | GO:0042382 | paraspeckles(GO:0042382) |
| 0.3 | 2.6 | GO:0045239 | tricarboxylic acid cycle enzyme complex(GO:0045239) |
| 0.3 | 1.0 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) extrinsic component of endosome membrane(GO:0031313) |
| 0.3 | 0.9 | GO:0042405 | nuclear inclusion body(GO:0042405) |
| 0.3 | 2.8 | GO:0070652 | HAUS complex(GO:0070652) |
| 0.3 | 1.6 | GO:0044452 | nucleolar part(GO:0044452) |
| 0.3 | 1.6 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
| 0.3 | 4.6 | GO:0000242 | pericentriolar material(GO:0000242) |
| 0.3 | 1.8 | GO:0009331 | glycerol-3-phosphate dehydrogenase complex(GO:0009331) |
| 0.3 | 1.2 | GO:0032301 | MutSalpha complex(GO:0032301) |
| 0.3 | 0.9 | GO:0035354 | Toll-like receptor 1-Toll-like receptor 2 protein complex(GO:0035354) |
| 0.3 | 2.4 | GO:0043596 | nuclear replication fork(GO:0043596) |
| 0.3 | 9.1 | GO:0005839 | proteasome core complex(GO:0005839) |
| 0.3 | 3.2 | GO:0016602 | CCAAT-binding factor complex(GO:0016602) |
| 0.3 | 11.3 | GO:0030530 | obsolete heterogeneous nuclear ribonucleoprotein complex(GO:0030530) |
| 0.3 | 3.2 | GO:0032040 | small-subunit processome(GO:0032040) |
| 0.3 | 1.1 | GO:0097651 | phosphatidylinositol 3-kinase complex, class IA(GO:0005943) phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
| 0.3 | 1.1 | GO:0001940 | male pronucleus(GO:0001940) |
| 0.3 | 1.7 | GO:0032444 | activin responsive factor complex(GO:0032444) |
| 0.3 | 4.1 | GO:0061200 | clathrin-sculpted gamma-aminobutyric acid transport vesicle(GO:0061200) clathrin-sculpted gamma-aminobutyric acid transport vesicle membrane(GO:0061202) |
| 0.3 | 1.1 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
| 0.3 | 6.6 | GO:0005689 | U12-type spliceosomal complex(GO:0005689) |
| 0.3 | 1.6 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
| 0.3 | 5.8 | GO:0000307 | cyclin-dependent protein kinase holoenzyme complex(GO:0000307) |
| 0.3 | 1.6 | GO:0031618 | nuclear pericentric heterochromatin(GO:0031618) |
| 0.3 | 1.1 | GO:0071664 | catenin-TCF7L2 complex(GO:0071664) |
| 0.3 | 2.7 | GO:0034518 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
| 0.3 | 1.6 | GO:0000931 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
| 0.3 | 1.6 | GO:0005750 | mitochondrial respiratory chain complex III(GO:0005750) respiratory chain complex III(GO:0045275) |
| 0.3 | 0.8 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
| 0.3 | 3.4 | GO:0005840 | ribosome(GO:0005840) |
| 0.3 | 2.4 | GO:0008180 | COP9 signalosome(GO:0008180) |
| 0.3 | 2.6 | GO:0045120 | pronucleus(GO:0045120) |
| 0.3 | 0.8 | GO:0005787 | signal peptidase complex(GO:0005787) |
| 0.3 | 1.0 | GO:0016593 | Cdc73/Paf1 complex(GO:0016593) |
| 0.3 | 2.0 | GO:0005675 | holo TFIIH complex(GO:0005675) |
| 0.3 | 19.8 | GO:0070469 | respiratory chain(GO:0070469) |
| 0.3 | 1.0 | GO:0016533 | cyclin-dependent protein kinase 5 holoenzyme complex(GO:0016533) |
| 0.2 | 1.0 | GO:0016939 | kinesin II complex(GO:0016939) |
| 0.2 | 16.9 | GO:0000777 | condensed chromosome kinetochore(GO:0000777) |
| 0.2 | 6.4 | GO:0044665 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
| 0.2 | 4.2 | GO:0016235 | aggresome(GO:0016235) |
| 0.2 | 1.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
| 0.2 | 15.8 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
| 0.2 | 0.9 | GO:0042272 | nuclear RNA export factor complex(GO:0042272) |
| 0.2 | 11.3 | GO:0015030 | Cajal body(GO:0015030) |
| 0.2 | 1.4 | GO:0000015 | phosphopyruvate hydratase complex(GO:0000015) |
| 0.2 | 0.2 | GO:0000805 | X chromosome(GO:0000805) |
| 0.2 | 1.1 | GO:0000791 | euchromatin(GO:0000791) |
| 0.2 | 3.9 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
| 0.2 | 1.4 | GO:0070552 | BRISC complex(GO:0070552) |
| 0.2 | 0.7 | GO:0031904 | endosome lumen(GO:0031904) |
| 0.2 | 3.6 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
| 0.2 | 2.6 | GO:0030125 | clathrin vesicle coat(GO:0030125) |
| 0.2 | 1.7 | GO:0032588 | trans-Golgi network membrane(GO:0032588) |
| 0.2 | 2.3 | GO:0071778 | obsolete WINAC complex(GO:0071778) |
| 0.2 | 0.4 | GO:0031229 | integral component of nuclear inner membrane(GO:0005639) intrinsic component of nuclear inner membrane(GO:0031229) nuclear membrane part(GO:0044453) |
| 0.2 | 1.4 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
| 0.2 | 1.7 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
| 0.2 | 0.6 | GO:0005956 | protein kinase CK2 complex(GO:0005956) |
| 0.2 | 0.2 | GO:0043564 | Ku70:Ku80 complex(GO:0043564) |
| 0.2 | 0.8 | GO:0005955 | calcineurin complex(GO:0005955) |
| 0.2 | 0.4 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
| 0.2 | 0.9 | GO:0031512 | motile primary cilium(GO:0031512) |
| 0.2 | 45.0 | GO:0005743 | mitochondrial inner membrane(GO:0005743) |
| 0.2 | 1.1 | GO:0005954 | calcium- and calmodulin-dependent protein kinase complex(GO:0005954) |
| 0.2 | 2.2 | GO:0032839 | dendrite cytoplasm(GO:0032839) |
| 0.2 | 3.0 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
| 0.2 | 0.4 | GO:0005873 | plus-end kinesin complex(GO:0005873) |
| 0.2 | 0.2 | GO:0019867 | outer membrane(GO:0019867) |
| 0.2 | 0.2 | GO:0044450 | microtubule organizing center part(GO:0044450) |
| 0.2 | 3.1 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
| 0.2 | 1.6 | GO:0005652 | nuclear lamina(GO:0005652) |
| 0.2 | 23.1 | GO:0016607 | nuclear speck(GO:0016607) |
| 0.2 | 0.2 | GO:0005682 | U5 snRNP(GO:0005682) |
| 0.2 | 14.6 | GO:0005643 | nuclear pore(GO:0005643) |
| 0.2 | 1.2 | GO:0031143 | pseudopodium(GO:0031143) |
| 0.2 | 0.3 | GO:0031258 | lamellipodium membrane(GO:0031258) |
| 0.2 | 4.8 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
| 0.2 | 4.1 | GO:0001772 | immunological synapse(GO:0001772) |
| 0.2 | 0.7 | GO:0016591 | DNA-directed RNA polymerase II, holoenzyme(GO:0016591) |
| 0.2 | 0.8 | GO:0072487 | MSL complex(GO:0072487) |
| 0.2 | 1.8 | GO:0005669 | transcription factor TFIID complex(GO:0005669) |
| 0.2 | 0.5 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
| 0.2 | 1.3 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
| 0.2 | 0.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
| 0.2 | 10.1 | GO:0016605 | PML body(GO:0016605) |
| 0.2 | 0.5 | GO:0098687 | chromosomal region(GO:0098687) |
| 0.2 | 2.4 | GO:0005833 | hemoglobin complex(GO:0005833) |
| 0.2 | 0.3 | GO:0030688 | preribosome, small subunit precursor(GO:0030688) |
| 0.2 | 3.7 | GO:0005758 | mitochondrial intermembrane space(GO:0005758) |
| 0.1 | 1.5 | GO:0030897 | HOPS complex(GO:0030897) |
| 0.1 | 7.2 | GO:0044815 | nucleosome(GO:0000786) DNA packaging complex(GO:0044815) |
| 0.1 | 0.6 | GO:0071256 | Sec61 translocon complex(GO:0005784) translocon complex(GO:0071256) |
| 0.1 | 1.1 | GO:0016942 | insulin-like growth factor binding protein complex(GO:0016942) growth factor complex(GO:0036454) |
| 0.1 | 4.2 | GO:0055038 | recycling endosome membrane(GO:0055038) |
| 0.1 | 0.6 | GO:0000930 | gamma-tubulin complex(GO:0000930) |
| 0.1 | 0.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
| 0.1 | 6.6 | GO:0000793 | condensed chromosome(GO:0000793) |
| 0.1 | 2.7 | GO:0005871 | kinesin complex(GO:0005871) |
| 0.1 | 5.1 | GO:0005814 | centriole(GO:0005814) |
| 0.1 | 2.3 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
| 0.1 | 0.7 | GO:0032389 | MutLalpha complex(GO:0032389) |
| 0.1 | 2.5 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
| 0.1 | 6.2 | GO:0005681 | spliceosomal complex(GO:0005681) |
| 0.1 | 1.5 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
| 0.1 | 0.3 | GO:0042827 | platelet dense granule membrane(GO:0031088) platelet dense granule(GO:0042827) |
| 0.1 | 1.3 | GO:0005678 | obsolete chromatin assembly complex(GO:0005678) |
| 0.1 | 0.4 | GO:0005610 | laminin-5 complex(GO:0005610) |
| 0.1 | 1.3 | GO:0035631 | CD40 receptor complex(GO:0035631) |
| 0.1 | 0.4 | GO:0042629 | mast cell granule(GO:0042629) |
| 0.1 | 1.2 | GO:0008290 | F-actin capping protein complex(GO:0008290) |
| 0.1 | 0.6 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
| 0.1 | 17.6 | GO:0031965 | nuclear membrane(GO:0031965) |
| 0.1 | 9.2 | GO:0070382 | exocytic vesicle(GO:0070382) |
| 0.1 | 5.9 | GO:0030136 | clathrin-coated vesicle(GO:0030136) |
| 0.1 | 2.4 | GO:0031201 | SNARE complex(GO:0031201) |
| 0.1 | 11.2 | GO:0005741 | mitochondrial outer membrane(GO:0005741) |
| 0.1 | 0.7 | GO:0005851 | eukaryotic translation initiation factor 2B complex(GO:0005851) |
| 0.1 | 0.3 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
| 0.1 | 0.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
| 0.1 | 0.5 | GO:0032449 | CBM complex(GO:0032449) |
| 0.1 | 2.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
| 0.1 | 0.5 | GO:0032993 | protein-DNA complex(GO:0032993) |
| 0.1 | 7.2 | GO:0022625 | cytosolic large ribosomal subunit(GO:0022625) |
| 0.1 | 0.3 | GO:0042788 | polysomal ribosome(GO:0042788) |
| 0.1 | 112.1 | GO:0005730 | nucleolus(GO:0005730) |
| 0.1 | 0.5 | GO:0043218 | compact myelin(GO:0043218) |
| 0.1 | 0.9 | GO:0030126 | COPI vesicle coat(GO:0030126) |
| 0.1 | 1.0 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
| 0.1 | 1.4 | GO:0044224 | juxtaparanode region of axon(GO:0044224) |
| 0.1 | 0.2 | GO:0098798 | mitochondrial protein complex(GO:0098798) |
| 0.1 | 2.1 | GO:0000299 | obsolete integral to membrane of membrane fraction(GO:0000299) |
| 0.1 | 0.4 | GO:0042597 | outer membrane-bounded periplasmic space(GO:0030288) periplasmic space(GO:0042597) |
| 0.1 | 0.1 | GO:0030673 | axolemma(GO:0030673) |
| 0.1 | 4.1 | GO:0030175 | filopodium(GO:0030175) |
| 0.1 | 3.6 | GO:0005884 | actin filament(GO:0005884) |
| 0.1 | 7.9 | GO:0008076 | voltage-gated potassium channel complex(GO:0008076) |
| 0.1 | 0.4 | GO:0005854 | nascent polypeptide-associated complex(GO:0005854) |
| 0.1 | 0.6 | GO:0042581 | specific granule(GO:0042581) |
| 0.1 | 0.3 | GO:0031083 | BLOC complex(GO:0031082) BLOC-1 complex(GO:0031083) |
| 0.1 | 0.4 | GO:0045298 | tubulin complex(GO:0045298) |
| 0.1 | 1.4 | GO:0033116 | endoplasmic reticulum-Golgi intermediate compartment membrane(GO:0033116) |
| 0.1 | 0.2 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
| 0.1 | 3.4 | GO:0044427 | chromosomal part(GO:0044427) |
| 0.1 | 0.3 | GO:0070188 | obsolete Stn1-Ten1 complex(GO:0070188) |
| 0.1 | 2.4 | GO:0045095 | keratin filament(GO:0045095) |
| 0.1 | 0.2 | GO:0032584 | growth cone membrane(GO:0032584) |
| 0.1 | 46.4 | GO:0031981 | nuclear lumen(GO:0031981) |
| 0.1 | 2.4 | GO:0000502 | proteasome complex(GO:0000502) |
| 0.1 | 0.3 | GO:0005876 | spindle microtubule(GO:0005876) |
| 0.1 | 0.2 | GO:0016328 | lateral plasma membrane(GO:0016328) |
| 0.1 | 0.6 | GO:0043034 | costamere(GO:0043034) |
| 0.1 | 1.6 | GO:0001533 | cornified envelope(GO:0001533) |
| 0.1 | 2.8 | GO:0005626 | obsolete insoluble fraction(GO:0005626) |
| 0.1 | 1.1 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
| 0.1 | 0.1 | GO:0005792 | obsolete microsome(GO:0005792) |
| 0.1 | 4.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
| 0.1 | 0.4 | GO:0033178 | proton-transporting two-sector ATPase complex, catalytic domain(GO:0033178) |
| 0.1 | 169.0 | GO:0005634 | nucleus(GO:0005634) |
| 0.1 | 2.1 | GO:0098857 | membrane raft(GO:0045121) membrane microdomain(GO:0098857) |
| 0.1 | 1.0 | GO:0046658 | anchored component of plasma membrane(GO:0046658) |
| 0.0 | 0.4 | GO:0042588 | zymogen granule(GO:0042588) |
| 0.0 | 0.2 | GO:0031205 | endoplasmic reticulum Sec complex(GO:0031205) |
| 0.0 | 0.4 | GO:0030315 | T-tubule(GO:0030315) |
| 0.0 | 0.2 | GO:0042599 | lamellar body(GO:0042599) |
| 0.0 | 0.2 | GO:0042105 | alpha-beta T cell receptor complex(GO:0042105) |
| 0.0 | 0.1 | GO:0097610 | cell division site(GO:0032153) cleavage furrow(GO:0032154) cell division site part(GO:0032155) cell surface furrow(GO:0097610) |
| 0.0 | 21.0 | GO:0005739 | mitochondrion(GO:0005739) |
| 0.0 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
| 0.0 | 0.1 | GO:0033391 | chromatoid body(GO:0033391) |
| 0.0 | 3.4 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
| 0.0 | 0.0 | GO:0071817 | MMXD complex(GO:0071817) |
| 0.0 | 0.0 | GO:0042584 | chromaffin granule(GO:0042583) chromaffin granule membrane(GO:0042584) |
| 0.0 | 0.1 | GO:0033017 | sarcoplasmic reticulum membrane(GO:0033017) |
| 0.0 | 0.1 | GO:0043209 | myelin sheath(GO:0043209) |
| 0.0 | 0.1 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
| 0.0 | 0.2 | GO:0043197 | dendritic spine(GO:0043197) |
| 0.0 | 0.4 | GO:0031526 | brush border membrane(GO:0031526) |
| 0.0 | 1.3 | GO:0043235 | receptor complex(GO:0043235) |
| 0.0 | 0.3 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
| 0.0 | 0.2 | GO:0005853 | eukaryotic translation elongation factor 1 complex(GO:0005853) |
| 0.0 | 1.2 | GO:0005789 | endoplasmic reticulum membrane(GO:0005789) nuclear outer membrane-endoplasmic reticulum membrane network(GO:0042175) |
| 0.0 | 1.3 | GO:0005765 | lysosomal membrane(GO:0005765) lytic vacuole membrane(GO:0098852) |
| 0.0 | 0.1 | GO:1903561 | extracellular organelle(GO:0043230) extracellular exosome(GO:0070062) extracellular vesicle(GO:1903561) |
| 0.0 | 0.0 | GO:0033011 | perinuclear theca(GO:0033011) cytoskeletal calyx(GO:0033150) |
| 0.0 | 0.0 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
| 0.0 | 0.2 | GO:0030017 | sarcomere(GO:0030017) |
| 0.0 | 0.4 | GO:0005770 | late endosome(GO:0005770) |
| 0.0 | 0.3 | GO:0043679 | axon terminus(GO:0043679) neuron projection terminus(GO:0044306) |
| 0.0 | 0.3 | GO:0044853 | caveola(GO:0005901) plasma membrane raft(GO:0044853) |
| 0.0 | 0.2 | GO:0005922 | connexon complex(GO:0005922) |
| 0.0 | 0.1 | GO:0042587 | glycogen granule(GO:0042587) |
| 0.0 | 0.3 | GO:0030666 | endocytic vesicle membrane(GO:0030666) |
| 0.0 | 0.7 | GO:0034707 | chloride channel complex(GO:0034707) |
| 0.0 | 0.2 | GO:0032982 | myosin filament(GO:0032982) |
| 0.0 | 1.2 | GO:0009897 | external side of plasma membrane(GO:0009897) |
Gene overrepresentation in molecular_function category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 2.0 | 5.9 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
| 2.0 | 7.9 | GO:0043140 | obsolete DNA strand annealing activity(GO:0000739) ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
| 1.6 | 9.7 | GO:0008649 | rRNA methyltransferase activity(GO:0008649) |
| 1.5 | 4.6 | GO:0004821 | histidine-tRNA ligase activity(GO:0004821) |
| 1.5 | 4.5 | GO:0033743 | peptide-methionine (R)-S-oxide reductase activity(GO:0033743) |
| 1.4 | 5.7 | GO:0016531 | copper chaperone activity(GO:0016531) |
| 1.4 | 4.1 | GO:0042610 | CD8 receptor binding(GO:0042610) |
| 1.2 | 11.1 | GO:0047429 | nucleoside-triphosphate diphosphatase activity(GO:0047429) |
| 1.2 | 11.8 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
| 1.2 | 5.9 | GO:0015216 | adenine nucleotide transmembrane transporter activity(GO:0000295) purine nucleotide transmembrane transporter activity(GO:0015216) |
| 1.1 | 5.6 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
| 1.1 | 3.4 | GO:0019976 | interleukin-2 binding(GO:0019976) |
| 1.1 | 15.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
| 1.1 | 4.3 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
| 1.1 | 3.2 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
| 1.1 | 4.3 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
| 1.1 | 4.2 | GO:0070259 | tyrosyl-DNA phosphodiesterase activity(GO:0070259) |
| 1.0 | 3.1 | GO:0004146 | dihydrofolate reductase activity(GO:0004146) |
| 1.0 | 3.0 | GO:0071566 | UFM1 activating enzyme activity(GO:0071566) |
| 1.0 | 2.9 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
| 0.9 | 3.8 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
| 0.9 | 4.7 | GO:0008599 | protein phosphatase type 1 regulator activity(GO:0008599) |
| 0.9 | 2.8 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) exoribonuclease II activity(GO:0008859) |
| 0.9 | 4.6 | GO:0000827 | inositol-1,3,4,5,6-pentakisphosphate kinase activity(GO:0000827) diphosphoinositol-pentakisphosphate kinase activity(GO:0033857) |
| 0.9 | 9.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
| 0.9 | 4.5 | GO:0008474 | palmitoyl-(protein) hydrolase activity(GO:0008474) palmitoyl hydrolase activity(GO:0098599) |
| 0.9 | 2.6 | GO:0034038 | deoxyhypusine synthase activity(GO:0034038) |
| 0.9 | 6.9 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
| 0.9 | 4.3 | GO:0042156 | obsolete zinc-mediated transcriptional activator activity(GO:0042156) |
| 0.9 | 2.6 | GO:0003896 | DNA primase activity(GO:0003896) |
| 0.8 | 3.9 | GO:0008327 | methyl-CpG binding(GO:0008327) |
| 0.8 | 1.6 | GO:0008138 | protein tyrosine/serine/threonine phosphatase activity(GO:0008138) |
| 0.8 | 3.0 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
| 0.7 | 4.4 | GO:0008269 | JAK pathway signal transduction adaptor activity(GO:0008269) |
| 0.7 | 2.9 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
| 0.7 | 2.2 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
| 0.7 | 9.4 | GO:0004526 | ribonuclease P activity(GO:0004526) |
| 0.7 | 2.1 | GO:0030621 | U4 snRNA binding(GO:0030621) |
| 0.7 | 12.0 | GO:0017025 | TBP-class protein binding(GO:0017025) |
| 0.7 | 10.5 | GO:0004532 | exoribonuclease activity(GO:0004532) |
| 0.7 | 6.8 | GO:0003701 | obsolete RNA polymerase I transcription factor activity(GO:0003701) |
| 0.7 | 25.8 | GO:0004527 | exonuclease activity(GO:0004527) |
| 0.7 | 7.5 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
| 0.7 | 4.7 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) L-lactate dehydrogenase activity(GO:0004459) |
| 0.7 | 4.0 | GO:0003872 | 6-phosphofructokinase activity(GO:0003872) |
| 0.7 | 2.0 | GO:0017129 | triglyceride binding(GO:0017129) |
| 0.6 | 3.9 | GO:0003917 | DNA topoisomerase type I activity(GO:0003917) |
| 0.6 | 0.6 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
| 0.6 | 2.5 | GO:0050265 | RNA uridylyltransferase activity(GO:0050265) |
| 0.6 | 1.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
| 0.6 | 3.1 | GO:0035197 | siRNA binding(GO:0035197) |
| 0.6 | 3.0 | GO:0015140 | malate transmembrane transporter activity(GO:0015140) |
| 0.6 | 5.4 | GO:0051019 | mitogen-activated protein kinase binding(GO:0051019) |
| 0.6 | 5.4 | GO:0016018 | cyclosporin A binding(GO:0016018) |
| 0.6 | 1.8 | GO:0022897 | peptide:proton symporter activity(GO:0015333) proton-dependent peptide secondary active transmembrane transporter activity(GO:0022897) |
| 0.6 | 1.2 | GO:0030337 | DNA polymerase processivity factor activity(GO:0030337) |
| 0.6 | 1.8 | GO:0008349 | MAP kinase kinase kinase kinase activity(GO:0008349) |
| 0.6 | 2.3 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
| 0.6 | 1.7 | GO:0042609 | CD4 receptor binding(GO:0042609) |
| 0.6 | 2.3 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
| 0.6 | 1.7 | GO:0036002 | pre-mRNA binding(GO:0036002) |
| 0.6 | 2.2 | GO:0047179 | platelet-activating factor acetyltransferase activity(GO:0047179) |
| 0.6 | 2.2 | GO:0048039 | ubiquinone binding(GO:0048039) |
| 0.5 | 2.7 | GO:0004766 | spermidine synthase activity(GO:0004766) |
| 0.5 | 2.7 | GO:0044020 | histone methyltransferase activity (H4-R3 specific)(GO:0044020) |
| 0.5 | 2.2 | GO:0035242 | protein-arginine omega-N asymmetric methyltransferase activity(GO:0035242) |
| 0.5 | 1.6 | GO:0044549 | GTP cyclohydrolase binding(GO:0044549) |
| 0.5 | 1.6 | GO:0004362 | glutathione-disulfide reductase activity(GO:0004362) |
| 0.5 | 1.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
| 0.5 | 5.7 | GO:0070513 | death domain binding(GO:0070513) |
| 0.5 | 1.6 | GO:0070324 | thyroid hormone binding(GO:0070324) |
| 0.5 | 0.5 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
| 0.5 | 2.6 | GO:0004111 | creatine kinase activity(GO:0004111) |
| 0.5 | 1.5 | GO:0016731 | ferredoxin-NADP+ reductase activity(GO:0004324) NADPH-adrenodoxin reductase activity(GO:0015039) oxidoreductase activity, acting on iron-sulfur proteins as donors(GO:0016730) oxidoreductase activity, acting on iron-sulfur proteins as donors, NAD or NADP as acceptor(GO:0016731) |
| 0.5 | 5.0 | GO:0030515 | snoRNA binding(GO:0030515) |
| 0.5 | 1.5 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
| 0.5 | 1.5 | GO:0000900 | translation repressor activity, nucleic acid binding(GO:0000900) |
| 0.5 | 2.0 | GO:0019788 | NEDD8 transferase activity(GO:0019788) |
| 0.5 | 2.0 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
| 0.5 | 0.5 | GO:0016278 | lysine N-methyltransferase activity(GO:0016278) protein-lysine N-methyltransferase activity(GO:0016279) |
| 0.5 | 1.5 | GO:0033765 | 3-oxo-5-alpha-steroid 4-dehydrogenase activity(GO:0003865) steroid dehydrogenase activity, acting on the CH-CH group of donors(GO:0033765) |
| 0.5 | 1.5 | GO:0017130 | poly(C) RNA binding(GO:0017130) |
| 0.5 | 4.9 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
| 0.5 | 1.0 | GO:0034061 | DNA polymerase activity(GO:0034061) |
| 0.5 | 3.9 | GO:0004522 | ribonuclease A activity(GO:0004522) |
| 0.5 | 0.5 | GO:0016004 | phospholipase activator activity(GO:0016004) lipase activator activity(GO:0060229) |
| 0.5 | 4.3 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
| 0.5 | 2.9 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
| 0.5 | 1.4 | GO:0004730 | pseudouridylate synthase activity(GO:0004730) |
| 0.5 | 0.5 | GO:0070215 | obsolete MDM2 binding(GO:0070215) |
| 0.5 | 2.3 | GO:0004830 | tryptophan-tRNA ligase activity(GO:0004830) |
| 0.5 | 1.8 | GO:0052590 | sn-glycerol-3-phosphate:ubiquinone oxidoreductase activity(GO:0052590) sn-glycerol-3-phosphate:ubiquinone-8 oxidoreductase activity(GO:0052591) |
| 0.5 | 2.3 | GO:0000993 | RNA polymerase II core binding(GO:0000993) |
| 0.5 | 3.2 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
| 0.5 | 4.1 | GO:0031489 | myosin V binding(GO:0031489) |
| 0.5 | 4.1 | GO:0019237 | centromeric DNA binding(GO:0019237) |
| 0.5 | 2.7 | GO:0005092 | GDP-dissociation inhibitor activity(GO:0005092) |
| 0.4 | 2.7 | GO:0050693 | LBD domain binding(GO:0050693) |
| 0.4 | 1.8 | GO:0008907 | integrase activity(GO:0008907) |
| 0.4 | 3.1 | GO:0030911 | TPR domain binding(GO:0030911) |
| 0.4 | 1.3 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
| 0.4 | 1.3 | GO:0000702 | oxidized base lesion DNA N-glycosylase activity(GO:0000702) |
| 0.4 | 3.0 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
| 0.4 | 1.7 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
| 0.4 | 12.0 | GO:0004129 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors(GO:0016675) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
| 0.4 | 3.4 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
| 0.4 | 2.9 | GO:0051879 | Hsp90 protein binding(GO:0051879) |
| 0.4 | 1.2 | GO:0016929 | SUMO-specific protease activity(GO:0016929) |
| 0.4 | 1.2 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
| 0.4 | 2.0 | GO:0004716 | receptor signaling protein tyrosine kinase activity(GO:0004716) |
| 0.4 | 0.8 | GO:0030172 | troponin C binding(GO:0030172) |
| 0.4 | 3.7 | GO:1901567 | icosanoid binding(GO:0050542) arachidonic acid binding(GO:0050544) fatty acid derivative binding(GO:1901567) |
| 0.4 | 2.0 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
| 0.4 | 1.2 | GO:0000156 | phosphorelay response regulator activity(GO:0000156) |
| 0.4 | 2.0 | GO:0019956 | chemokine binding(GO:0019956) |
| 0.4 | 2.4 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
| 0.4 | 1.2 | GO:0035403 | histone kinase activity (H3-T6 specific)(GO:0035403) |
| 0.4 | 5.5 | GO:0000339 | RNA cap binding(GO:0000339) |
| 0.4 | 5.1 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
| 0.4 | 1.2 | GO:0015361 | low-affinity sodium:dicarboxylate symporter activity(GO:0015361) |
| 0.4 | 2.8 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
| 0.4 | 1.6 | GO:0046404 | ATP-dependent polydeoxyribonucleotide 5'-hydroxyl-kinase activity(GO:0046404) polydeoxyribonucleotide kinase activity(GO:0051733) ATP-dependent polynucleotide kinase activity(GO:0051734) |
| 0.4 | 6.6 | GO:0017069 | snRNA binding(GO:0017069) |
| 0.4 | 1.6 | GO:0098847 | single-stranded telomeric DNA binding(GO:0043047) sequence-specific single stranded DNA binding(GO:0098847) |
| 0.4 | 3.5 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
| 0.4 | 1.2 | GO:0008263 | mismatch base pair DNA N-glycosylase activity(GO:0000700) pyrimidine-specific mismatch base pair DNA N-glycosylase activity(GO:0008263) |
| 0.4 | 1.2 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
| 0.4 | 3.8 | GO:0003688 | DNA replication origin binding(GO:0003688) |
| 0.4 | 1.1 | GO:0042289 | MHC class II protein binding(GO:0042289) |
| 0.4 | 1.5 | GO:0008574 | ATP-dependent microtubule motor activity, plus-end-directed(GO:0008574) ATP-dependent microtubule motor activity(GO:1990939) |
| 0.4 | 1.9 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) O-palmitoyltransferase activity(GO:0016416) |
| 0.4 | 1.1 | GO:0004618 | phosphoglycerate kinase activity(GO:0004618) |
| 0.4 | 3.0 | GO:0016723 | oxidoreductase activity, oxidizing metal ions, NAD or NADP as acceptor(GO:0016723) |
| 0.4 | 4.4 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
| 0.4 | 17.7 | GO:0003899 | DNA-directed RNA polymerase activity(GO:0003899) RNA polymerase activity(GO:0034062) |
| 0.4 | 6.2 | GO:0005522 | profilin binding(GO:0005522) |
| 0.4 | 1.5 | GO:0004307 | ethanolaminephosphotransferase activity(GO:0004307) |
| 0.4 | 0.4 | GO:0070643 | vitamin D3 25-hydroxylase activity(GO:0030343) vitamin D 25-hydroxylase activity(GO:0070643) |
| 0.4 | 2.2 | GO:0005345 | purine nucleobase transmembrane transporter activity(GO:0005345) |
| 0.4 | 4.6 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
| 0.4 | 2.1 | GO:0000268 | peroxisome targeting sequence binding(GO:0000268) |
| 0.4 | 3.2 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
| 0.3 | 2.4 | GO:0015651 | quaternary ammonium group transmembrane transporter activity(GO:0015651) |
| 0.3 | 3.8 | GO:0035173 | histone kinase activity(GO:0035173) |
| 0.3 | 2.1 | GO:0046934 | phosphatidylinositol-4,5-bisphosphate 3-kinase activity(GO:0046934) phosphatidylinositol bisphosphate kinase activity(GO:0052813) |
| 0.3 | 1.0 | GO:0033858 | N-acetylgalactosamine kinase activity(GO:0033858) |
| 0.3 | 2.7 | GO:0070087 | chromo shadow domain binding(GO:0070087) |
| 0.3 | 2.7 | GO:0090599 | alpha-glucosidase activity(GO:0090599) |
| 0.3 | 6.5 | GO:0016251 | obsolete general RNA polymerase II transcription factor activity(GO:0016251) |
| 0.3 | 1.9 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
| 0.3 | 3.2 | GO:0061659 | ubiquitin-ubiquitin ligase activity(GO:0034450) ubiquitin protein ligase activity(GO:0061630) ubiquitin-like protein ligase activity(GO:0061659) |
| 0.3 | 1.3 | GO:0004852 | uroporphyrinogen-III synthase activity(GO:0004852) |
| 0.3 | 6.1 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
| 0.3 | 9.6 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
| 0.3 | 4.1 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, RNA polymerase II basal transcription factor binding(GO:0001083) transcription factor activity, TFIIB-class binding(GO:0001087) RNA polymerase II basal transcription factor binding(GO:0001091) TFIIB-class transcription factor binding(GO:0001093) basal transcription machinery binding(GO:0001098) basal RNA polymerase II transcription machinery binding(GO:0001099) |
| 0.3 | 1.2 | GO:0047315 | kynurenine-glyoxylate transaminase activity(GO:0047315) |
| 0.3 | 9.9 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
| 0.3 | 0.9 | GO:0070568 | guanylyltransferase activity(GO:0070568) |
| 0.3 | 0.9 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
| 0.3 | 1.5 | GO:0003827 | alpha-1,3-mannosylglycoprotein 2-beta-N-acetylglucosaminyltransferase activity(GO:0003827) |
| 0.3 | 1.2 | GO:0005048 | signal sequence binding(GO:0005048) |
| 0.3 | 1.8 | GO:0003747 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
| 0.3 | 1.8 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
| 0.3 | 7.4 | GO:0005487 | nucleocytoplasmic transporter activity(GO:0005487) |
| 0.3 | 2.1 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
| 0.3 | 1.5 | GO:0017159 | pantetheine hydrolase activity(GO:0017159) |
| 0.3 | 0.9 | GO:0070283 | lipoate-protein ligase activity(GO:0016979) lipoate synthase activity(GO:0016992) radical SAM enzyme activity(GO:0070283) |
| 0.3 | 2.6 | GO:0004128 | cytochrome-b5 reductase activity, acting on NAD(P)H(GO:0004128) |
| 0.3 | 1.7 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
| 0.3 | 0.9 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
| 0.3 | 0.6 | GO:0032089 | NACHT domain binding(GO:0032089) |
| 0.3 | 0.9 | GO:0031686 | A1 adenosine receptor binding(GO:0031686) |
| 0.3 | 1.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
| 0.3 | 0.6 | GO:0042895 | antibiotic transporter activity(GO:0042895) |
| 0.3 | 2.8 | GO:0008499 | UDP-galactose:beta-N-acetylglucosamine beta-1,3-galactosyltransferase activity(GO:0008499) |
| 0.3 | 3.6 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
| 0.3 | 2.7 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
| 0.3 | 0.8 | GO:0003863 | alpha-ketoacid dehydrogenase activity(GO:0003826) 3-methyl-2-oxobutanoate dehydrogenase (2-methylpropanoyl-transferring) activity(GO:0003863) |
| 0.3 | 0.5 | GO:0015254 | glycerol channel activity(GO:0015254) |
| 0.3 | 1.9 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
| 0.3 | 2.1 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
| 0.3 | 0.8 | GO:0004609 | phosphatidylserine decarboxylase activity(GO:0004609) |
| 0.3 | 1.8 | GO:0004340 | glucokinase activity(GO:0004340) |
| 0.3 | 1.8 | GO:0030492 | hemoglobin binding(GO:0030492) |
| 0.3 | 0.8 | GO:0004809 | tRNA (guanine-N2-)-methyltransferase activity(GO:0004809) |
| 0.3 | 1.3 | GO:0004485 | methylcrotonoyl-CoA carboxylase activity(GO:0004485) |
| 0.3 | 1.3 | GO:0051400 | BH domain binding(GO:0051400) |
| 0.3 | 1.3 | GO:0004339 | glucan 1,4-alpha-glucosidase activity(GO:0004339) |
| 0.3 | 0.8 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
| 0.3 | 8.7 | GO:0016814 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amidines(GO:0016814) |
| 0.3 | 2.0 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
| 0.3 | 2.3 | GO:0042169 | SH2 domain binding(GO:0042169) |
| 0.3 | 1.3 | GO:0034618 | arginine binding(GO:0034618) |
| 0.3 | 2.0 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
| 0.3 | 7.9 | GO:0050699 | WW domain binding(GO:0050699) |
| 0.3 | 0.8 | GO:0032090 | Pyrin domain binding(GO:0032090) |
| 0.2 | 0.7 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
| 0.2 | 1.0 | GO:0004844 | uracil DNA N-glycosylase activity(GO:0004844) deaminated base DNA N-glycosylase activity(GO:0097506) |
| 0.2 | 1.0 | GO:0004727 | prenylated protein tyrosine phosphatase activity(GO:0004727) |
| 0.2 | 0.2 | GO:0051731 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) |
| 0.2 | 1.2 | GO:0004489 | methylenetetrahydrofolate reductase (NAD(P)H) activity(GO:0004489) |
| 0.2 | 15.5 | GO:0003743 | translation initiation factor activity(GO:0003743) |
| 0.2 | 1.2 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
| 0.2 | 0.7 | GO:0003978 | UDP-glucose 4-epimerase activity(GO:0003978) |
| 0.2 | 6.6 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
| 0.2 | 1.6 | GO:0016206 | catechol O-methyltransferase activity(GO:0016206) |
| 0.2 | 1.6 | GO:0016409 | palmitoyltransferase activity(GO:0016409) |
| 0.2 | 1.4 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
| 0.2 | 0.7 | GO:0003878 | ATP citrate synthase activity(GO:0003878) |
| 0.2 | 1.4 | GO:0004634 | phosphopyruvate hydratase activity(GO:0004634) |
| 0.2 | 0.2 | GO:0016922 | ligand-dependent nuclear receptor binding(GO:0016922) |
| 0.2 | 3.9 | GO:0019992 | diacylglycerol binding(GO:0019992) |
| 0.2 | 1.1 | GO:0043559 | insulin binding(GO:0043559) |
| 0.2 | 12.1 | GO:0050136 | NADH dehydrogenase activity(GO:0003954) NADH dehydrogenase (ubiquinone) activity(GO:0008137) NADH dehydrogenase (quinone) activity(GO:0050136) |
| 0.2 | 3.0 | GO:0050998 | nitric-oxide synthase binding(GO:0050998) |
| 0.2 | 0.7 | GO:0030368 | interleukin-17 receptor activity(GO:0030368) |
| 0.2 | 1.1 | GO:0008237 | metallopeptidase activity(GO:0008237) |
| 0.2 | 2.2 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
| 0.2 | 0.7 | GO:0015193 | L-proline transmembrane transporter activity(GO:0015193) |
| 0.2 | 1.3 | GO:0048156 | tau protein binding(GO:0048156) |
| 0.2 | 0.7 | GO:0051765 | obsolete inositol-1,3,4-trisphosphate 5/6-kinase activity(GO:0035300) inositol tetrakisphosphate 1-kinase activity(GO:0047325) inositol tetrakisphosphate kinase activity(GO:0051765) |
| 0.2 | 2.2 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
| 0.2 | 0.7 | GO:0004540 | ribonuclease activity(GO:0004540) |
| 0.2 | 3.1 | GO:0003678 | DNA helicase activity(GO:0003678) |
| 0.2 | 0.4 | GO:0032138 | single base insertion or deletion binding(GO:0032138) |
| 0.2 | 1.7 | GO:0035258 | steroid hormone receptor binding(GO:0035258) |
| 0.2 | 0.4 | GO:0044877 | macromolecular complex binding(GO:0044877) |
| 0.2 | 0.9 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
| 0.2 | 0.6 | GO:0004347 | glucose-6-phosphate isomerase activity(GO:0004347) |
| 0.2 | 2.5 | GO:0017091 | AU-rich element binding(GO:0017091) |
| 0.2 | 2.3 | GO:0030274 | LIM domain binding(GO:0030274) |
| 0.2 | 1.2 | GO:0052654 | branched-chain-amino-acid transaminase activity(GO:0004084) L-leucine transaminase activity(GO:0052654) L-valine transaminase activity(GO:0052655) L-isoleucine transaminase activity(GO:0052656) |
| 0.2 | 4.4 | GO:0005095 | GTPase inhibitor activity(GO:0005095) |
| 0.2 | 1.0 | GO:0070363 | mitochondrial light strand promoter sense binding(GO:0070363) |
| 0.2 | 2.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
| 0.2 | 0.8 | GO:0031435 | mitogen-activated protein kinase kinase kinase binding(GO:0031435) |
| 0.2 | 1.8 | GO:0008517 | folic acid transporter activity(GO:0008517) |
| 0.2 | 0.8 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
| 0.2 | 1.1 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
| 0.2 | 1.3 | GO:0042800 | histone methyltransferase activity (H3-K4 specific)(GO:0042800) |
| 0.2 | 1.7 | GO:0008432 | JUN kinase binding(GO:0008432) |
| 0.2 | 0.2 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) phosphate transmembrane transporter activity(GO:1901677) |
| 0.2 | 2.2 | GO:0043560 | insulin receptor substrate binding(GO:0043560) |
| 0.2 | 0.5 | GO:0043515 | kinetochore binding(GO:0043515) |
| 0.2 | 7.9 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
| 0.2 | 2.9 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
| 0.2 | 3.2 | GO:0030296 | protein tyrosine kinase activator activity(GO:0030296) |
| 0.2 | 1.8 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
| 0.2 | 2.8 | GO:0003702 | obsolete RNA polymerase II transcription factor activity(GO:0003702) |
| 0.2 | 0.2 | GO:0003711 | obsolete transcription elongation regulator activity(GO:0003711) |
| 0.2 | 1.2 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
| 0.2 | 1.2 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
| 0.2 | 0.5 | GO:0003870 | 5-aminolevulinate synthase activity(GO:0003870) N-succinyltransferase activity(GO:0016749) |
| 0.2 | 0.7 | GO:0004663 | protein geranylgeranyltransferase activity(GO:0004661) Rab geranylgeranyltransferase activity(GO:0004663) |
| 0.2 | 1.6 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
| 0.2 | 0.2 | GO:0035591 | signaling adaptor activity(GO:0035591) |
| 0.2 | 0.5 | GO:0016565 | obsolete general transcriptional repressor activity(GO:0016565) |
| 0.2 | 0.5 | GO:0016167 | glial cell-derived neurotrophic factor receptor activity(GO:0016167) |
| 0.2 | 0.7 | GO:0004723 | calcium-dependent protein serine/threonine phosphatase activity(GO:0004723) |
| 0.2 | 0.5 | GO:0005047 | signal recognition particle binding(GO:0005047) |
| 0.2 | 4.7 | GO:0045296 | cadherin binding(GO:0045296) |
| 0.2 | 0.5 | GO:0046625 | sphingolipid binding(GO:0046625) |
| 0.2 | 1.5 | GO:0031628 | opioid receptor binding(GO:0031628) mu-type opioid receptor binding(GO:0031852) |
| 0.2 | 12.2 | GO:0008026 | ATP-dependent helicase activity(GO:0008026) purine NTP-dependent helicase activity(GO:0070035) |
| 0.2 | 1.6 | GO:0030331 | estrogen receptor binding(GO:0030331) |
| 0.2 | 1.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
| 0.2 | 4.8 | GO:0046966 | thyroid hormone receptor binding(GO:0046966) |
| 0.2 | 4.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
| 0.2 | 1.9 | GO:0003709 | obsolete RNA polymerase III transcription factor activity(GO:0003709) |
| 0.2 | 0.5 | GO:0015386 | potassium:proton antiporter activity(GO:0015386) |
| 0.2 | 0.2 | GO:0042799 | histone methyltransferase activity (H4-K20 specific)(GO:0042799) |
| 0.2 | 1.7 | GO:0016944 | obsolete RNA polymerase II transcription elongation factor activity(GO:0016944) |
| 0.2 | 0.2 | GO:0033613 | activating transcription factor binding(GO:0033613) |
| 0.2 | 0.5 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
| 0.2 | 0.5 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
| 0.2 | 0.3 | GO:0052742 | phosphatidylinositol kinase activity(GO:0052742) |
| 0.2 | 2.0 | GO:0005542 | folic acid binding(GO:0005542) |
| 0.2 | 3.3 | GO:1901505 | carbohydrate derivative transporter activity(GO:1901505) |
| 0.2 | 0.5 | GO:0031997 | N-terminal myristoylation domain binding(GO:0031997) |
| 0.2 | 2.3 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
| 0.2 | 1.1 | GO:0004351 | glutamate decarboxylase activity(GO:0004351) |
| 0.1 | 0.9 | GO:0015410 | manganese-transporting ATPase activity(GO:0015410) |
| 0.1 | 2.2 | GO:0030276 | clathrin binding(GO:0030276) |
| 0.1 | 1.6 | GO:0070403 | NAD+ binding(GO:0070403) |
| 0.1 | 0.6 | GO:0004826 | phenylalanine-tRNA ligase activity(GO:0004826) |
| 0.1 | 0.9 | GO:0004659 | prenyltransferase activity(GO:0004659) |
| 0.1 | 0.6 | GO:0035014 | phosphatidylinositol 3-kinase regulator activity(GO:0035014) |
| 0.1 | 0.3 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
| 0.1 | 0.9 | GO:0004470 | malic enzyme activity(GO:0004470) |
| 0.1 | 10.8 | GO:0051015 | actin filament binding(GO:0051015) |
| 0.1 | 0.1 | GO:0016748 | succinyltransferase activity(GO:0016748) |
| 0.1 | 0.6 | GO:0050220 | prostaglandin-E synthase activity(GO:0050220) |
| 0.1 | 0.3 | GO:0042978 | ornithine decarboxylase activator activity(GO:0042978) |
| 0.1 | 1.1 | GO:0043531 | ADP binding(GO:0043531) |
| 0.1 | 0.1 | GO:0004175 | endopeptidase activity(GO:0004175) |
| 0.1 | 0.6 | GO:0033981 | D-dopachrome decarboxylase activity(GO:0033981) |
| 0.1 | 1.7 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
| 0.1 | 4.9 | GO:0042054 | histone methyltransferase activity(GO:0042054) |
| 0.1 | 0.4 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
| 0.1 | 1.0 | GO:0008320 | protein transmembrane transporter activity(GO:0008320) |
| 0.1 | 3.6 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
| 0.1 | 4.3 | GO:0004386 | helicase activity(GO:0004386) |
| 0.1 | 0.5 | GO:0016404 | 15-hydroxyprostaglandin dehydrogenase (NAD+) activity(GO:0016404) |
| 0.1 | 1.5 | GO:0004332 | fructose-bisphosphate aldolase activity(GO:0004332) |
| 0.1 | 0.5 | GO:0015037 | peptide disulfide oxidoreductase activity(GO:0015037) |
| 0.1 | 0.4 | GO:0042285 | UDP-xylosyltransferase activity(GO:0035252) xylosyltransferase activity(GO:0042285) |
| 0.1 | 0.5 | GO:0061133 | endopeptidase activator activity(GO:0061133) |
| 0.1 | 0.4 | GO:0043398 | HLH domain binding(GO:0043398) |
| 0.1 | 0.9 | GO:0008732 | glycine hydroxymethyltransferase activity(GO:0004372) threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
| 0.1 | 0.4 | GO:0008670 | 2,4-dienoyl-CoA reductase (NADPH) activity(GO:0008670) |
| 0.1 | 0.9 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
| 0.1 | 1.7 | GO:0005123 | death receptor binding(GO:0005123) |
| 0.1 | 0.7 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
| 0.1 | 1.7 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
| 0.1 | 1.6 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
| 0.1 | 0.3 | GO:0015018 | galactosylgalactosylxylosylprotein 3-beta-glucuronosyltransferase activity(GO:0015018) |
| 0.1 | 0.4 | GO:0004376 | glycolipid mannosyltransferase activity(GO:0004376) |
| 0.1 | 0.4 | GO:0050473 | arachidonate 15-lipoxygenase activity(GO:0050473) |
| 0.1 | 16.4 | GO:0001071 | nucleic acid binding transcription factor activity(GO:0001071) transcription factor activity, sequence-specific DNA binding(GO:0003700) |
| 0.1 | 15.6 | GO:0004725 | protein tyrosine phosphatase activity(GO:0004725) |
| 0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
| 0.1 | 1.5 | GO:0030295 | protein kinase activator activity(GO:0030295) |
| 0.1 | 0.3 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
| 0.1 | 0.5 | GO:0070064 | proline-rich region binding(GO:0070064) |
| 0.1 | 0.4 | GO:0003831 | beta-N-acetylglucosaminylglycopeptide beta-1,4-galactosyltransferase activity(GO:0003831) |
| 0.1 | 1.7 | GO:0015269 | calcium-activated potassium channel activity(GO:0015269) |
| 0.1 | 2.4 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
| 0.1 | 0.8 | GO:0016494 | C-X-C chemokine receptor activity(GO:0016494) |
| 0.1 | 4.9 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
| 0.1 | 1.4 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
| 0.1 | 1.4 | GO:0005344 | oxygen transporter activity(GO:0005344) |
| 0.1 | 0.4 | GO:0004756 | selenide, water dikinase activity(GO:0004756) phosphotransferase activity, paired acceptors(GO:0016781) |
| 0.1 | 2.0 | GO:0008198 | ferrous iron binding(GO:0008198) |
| 0.1 | 0.4 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) |
| 0.1 | 0.2 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
| 0.1 | 3.6 | GO:0004435 | phosphatidylinositol phospholipase C activity(GO:0004435) |
| 0.1 | 0.1 | GO:0050815 | phosphoserine binding(GO:0050815) phosphothreonine binding(GO:0050816) |
| 0.1 | 0.8 | GO:0051537 | 2 iron, 2 sulfur cluster binding(GO:0051537) |
| 0.1 | 6.0 | GO:0003823 | antigen binding(GO:0003823) |
| 0.1 | 1.6 | GO:0005521 | lamin binding(GO:0005521) |
| 0.1 | 2.7 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
| 0.1 | 1.3 | GO:0042288 | MHC class I protein binding(GO:0042288) |
| 0.1 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
| 0.1 | 0.2 | GO:0043425 | bHLH transcription factor binding(GO:0043425) |
| 0.1 | 1.3 | GO:0051635 | obsolete bacterial cell surface binding(GO:0051635) |
| 0.1 | 0.6 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
| 0.1 | 4.5 | GO:0042826 | histone deacetylase binding(GO:0042826) |
| 0.1 | 4.2 | GO:0036459 | thiol-dependent ubiquitin-specific protease activity(GO:0004843) thiol-dependent ubiquitinyl hydrolase activity(GO:0036459) ubiquitinyl hydrolase activity(GO:0101005) |
| 0.1 | 0.3 | GO:0004949 | cannabinoid receptor activity(GO:0004949) |
| 0.1 | 6.2 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
| 0.1 | 4.8 | GO:0015459 | potassium channel regulator activity(GO:0015459) |
| 0.1 | 0.3 | GO:0004803 | transposase activity(GO:0004803) |
| 0.1 | 0.7 | GO:0031996 | thioesterase binding(GO:0031996) |
| 0.1 | 0.7 | GO:0045502 | dynein binding(GO:0045502) |
| 0.1 | 2.2 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
| 0.1 | 0.1 | GO:0030611 | arsenate reductase activity(GO:0030611) |
| 0.1 | 3.8 | GO:0004402 | histone acetyltransferase activity(GO:0004402) |
| 0.1 | 0.6 | GO:0008526 | phosphatidylinositol transporter activity(GO:0008526) |
| 0.1 | 0.2 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) norepinephrine binding(GO:0051380) |
| 0.1 | 18.6 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
| 0.1 | 0.3 | GO:0050062 | long-chain-fatty-acyl-CoA reductase activity(GO:0050062) |
| 0.1 | 8.4 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
| 0.1 | 4.0 | GO:0003682 | chromatin binding(GO:0003682) |
| 0.1 | 0.5 | GO:0031434 | mitogen-activated protein kinase kinase binding(GO:0031434) |
| 0.1 | 1.7 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
| 0.1 | 1.9 | GO:0004683 | calmodulin-dependent protein kinase activity(GO:0004683) |
| 0.1 | 1.2 | GO:0042162 | telomeric DNA binding(GO:0042162) |
| 0.1 | 0.2 | GO:0003720 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
| 0.1 | 0.3 | GO:0008424 | glycoprotein 6-alpha-L-fucosyltransferase activity(GO:0008424) alpha-(1->6)-fucosyltransferase activity(GO:0046921) |
| 0.1 | 0.2 | GO:0005174 | CD40 receptor binding(GO:0005174) |
| 0.1 | 1.4 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
| 0.1 | 1.0 | GO:0001727 | lipid kinase activity(GO:0001727) |
| 0.1 | 0.4 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
| 0.1 | 0.3 | GO:0035276 | aldehyde oxidase activity(GO:0004031) ethanol binding(GO:0035276) |
| 0.1 | 0.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
| 0.1 | 2.1 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
| 0.1 | 0.3 | GO:0019789 | SUMO transferase activity(GO:0019789) |
| 0.1 | 0.3 | GO:0019104 | DNA N-glycosylase activity(GO:0019104) |
| 0.1 | 0.9 | GO:0047555 | 3',5'-cyclic-nucleotide phosphodiesterase activity(GO:0004114) 3',5'-cyclic-GMP phosphodiesterase activity(GO:0047555) |
| 0.1 | 0.3 | GO:0035259 | glucocorticoid receptor binding(GO:0035259) |
| 0.1 | 0.3 | GO:0031402 | sodium ion binding(GO:0031402) |
| 0.1 | 0.4 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
| 0.1 | 2.5 | GO:0005242 | inward rectifier potassium channel activity(GO:0005242) |
| 0.1 | 0.2 | GO:0016418 | S-acetyltransferase activity(GO:0016418) |
| 0.1 | 0.5 | GO:0005000 | vasopressin receptor activity(GO:0005000) |
| 0.1 | 3.0 | GO:0016875 | aminoacyl-tRNA ligase activity(GO:0004812) ligase activity, forming carbon-oxygen bonds(GO:0016875) ligase activity, forming aminoacyl-tRNA and related compounds(GO:0016876) |
| 0.1 | 0.1 | GO:0016151 | nickel cation binding(GO:0016151) |
| 0.1 | 0.4 | GO:0019003 | GDP binding(GO:0019003) |
| 0.1 | 0.2 | GO:0070577 | lysine-acetylated histone binding(GO:0070577) |
| 0.1 | 1.2 | GO:0016835 | carbon-oxygen lyase activity(GO:0016835) |
| 0.1 | 0.4 | GO:0070644 | vitamin D response element binding(GO:0070644) |
| 0.1 | 0.3 | GO:0000033 | alpha-1,3-mannosyltransferase activity(GO:0000033) |
| 0.1 | 0.8 | GO:0002039 | p53 binding(GO:0002039) |
| 0.1 | 1.2 | GO:0004190 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
| 0.1 | 0.4 | GO:0001849 | complement component C1q binding(GO:0001849) |
| 0.1 | 184.4 | GO:0003677 | DNA binding(GO:0003677) |
| 0.1 | 0.4 | GO:0034701 | tripeptidase activity(GO:0034701) |
| 0.1 | 0.9 | GO:0051059 | NF-kappaB binding(GO:0051059) |
| 0.1 | 0.2 | GO:0043023 | ribosomal large subunit binding(GO:0043023) |
| 0.1 | 3.0 | GO:0016811 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amides(GO:0016811) |
| 0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
| 0.1 | 2.8 | GO:0019905 | syntaxin binding(GO:0019905) |
| 0.1 | 0.8 | GO:0035381 | extracellular ATP-gated cation channel activity(GO:0004931) ATP-gated ion channel activity(GO:0035381) |
| 0.1 | 0.2 | GO:0034235 | GPI anchor binding(GO:0034235) |
| 0.1 | 0.4 | GO:0042132 | fructose 1,6-bisphosphate 1-phosphatase activity(GO:0042132) |
| 0.1 | 3.7 | GO:0016779 | nucleotidyltransferase activity(GO:0016779) |
| 0.1 | 1.1 | GO:0008139 | nuclear localization sequence binding(GO:0008139) |
| 0.1 | 0.3 | GO:0016857 | racemase and epimerase activity, acting on carbohydrates and derivatives(GO:0016857) |
| 0.1 | 1.2 | GO:0005507 | copper ion binding(GO:0005507) |
| 0.1 | 1.2 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
| 0.1 | 0.2 | GO:0004704 | NF-kappaB-inducing kinase activity(GO:0004704) |
| 0.1 | 0.2 | GO:0046912 | transferase activity, transferring acyl groups, acyl groups converted into alkyl on transfer(GO:0046912) |
| 0.1 | 0.2 | GO:0008107 | galactoside 2-alpha-L-fucosyltransferase activity(GO:0008107) alpha-(1,2)-fucosyltransferase activity(GO:0031127) |
| 0.1 | 1.1 | GO:0008173 | RNA methyltransferase activity(GO:0008173) |
| 0.1 | 1.4 | GO:0005003 | ephrin receptor activity(GO:0005003) |
| 0.1 | 0.3 | GO:0019961 | interferon binding(GO:0019961) |
| 0.1 | 1.0 | GO:0000049 | tRNA binding(GO:0000049) |
| 0.1 | 0.4 | GO:0042577 | lipid phosphatase activity(GO:0042577) |
| 0.1 | 5.3 | GO:0030246 | carbohydrate binding(GO:0030246) |
| 0.1 | 0.2 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
| 0.1 | 1.1 | GO:0004518 | nuclease activity(GO:0004518) |
| 0.1 | 0.2 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
| 0.1 | 0.5 | GO:0004767 | sphingomyelin phosphodiesterase activity(GO:0004767) |
| 0.1 | 18.7 | GO:0003924 | GTPase activity(GO:0003924) |
| 0.1 | 1.8 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
| 0.1 | 0.9 | GO:0019864 | IgG binding(GO:0019864) |
| 0.1 | 15.5 | GO:0019787 | ubiquitin-like protein transferase activity(GO:0019787) |
| 0.1 | 0.2 | GO:0004603 | phenylethanolamine N-methyltransferase activity(GO:0004603) |
| 0.1 | 0.5 | GO:0050780 | dopamine receptor binding(GO:0050780) |
| 0.1 | 0.4 | GO:0016453 | C-acetyltransferase activity(GO:0016453) |
| 0.1 | 0.3 | GO:0016822 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
| 0.1 | 0.5 | GO:0015288 | porin activity(GO:0015288) |
| 0.1 | 0.5 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
| 0.1 | 0.2 | GO:0045155 | electron transporter, transferring electrons from CoQH2-cytochrome c reductase complex and cytochrome c oxidase complex activity(GO:0045155) |
| 0.1 | 0.3 | GO:0003847 | 1-alkyl-2-acetylglycerophosphocholine esterase activity(GO:0003847) |
| 0.1 | 0.4 | GO:0019966 | interleukin-1 binding(GO:0019966) |
| 0.1 | 0.4 | GO:0005534 | galactose binding(GO:0005534) |
| 0.1 | 0.7 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
| 0.1 | 1.3 | GO:0036442 | hydrogen-exporting ATPase activity(GO:0036442) proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
| 0.1 | 0.2 | GO:0001846 | opsonin binding(GO:0001846) |
| 0.1 | 0.6 | GO:0004143 | diacylglycerol kinase activity(GO:0004143) |
| 0.1 | 0.2 | GO:0004960 | thromboxane receptor activity(GO:0004960) thromboxane A2 receptor activity(GO:0004961) |
| 0.1 | 2.0 | GO:0030145 | manganese ion binding(GO:0030145) |
| 0.1 | 0.2 | GO:0005222 | intracellular cAMP activated cation channel activity(GO:0005222) |
| 0.1 | 5.6 | GO:0005178 | integrin binding(GO:0005178) |
| 0.1 | 13.3 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
| 0.1 | 0.3 | GO:0004102 | choline O-acetyltransferase activity(GO:0004102) |
| 0.1 | 0.1 | GO:0004024 | alcohol dehydrogenase activity, zinc-dependent(GO:0004024) |
| 0.1 | 0.3 | GO:0001965 | G-protein alpha-subunit binding(GO:0001965) |
| 0.1 | 0.1 | GO:0004607 | phosphatidylcholine-sterol O-acyltransferase activity(GO:0004607) |
| 0.1 | 0.2 | GO:0030942 | endoplasmic reticulum signal peptide binding(GO:0030942) |
| 0.1 | 2.6 | GO:0001948 | glycoprotein binding(GO:0001948) |
| 0.1 | 1.5 | GO:0042393 | histone binding(GO:0042393) |
| 0.1 | 0.8 | GO:0047617 | acyl-CoA hydrolase activity(GO:0047617) |
| 0.1 | 33.1 | GO:0003676 | nucleic acid binding(GO:0003676) |
| 0.1 | 0.7 | GO:0030676 | Rac guanyl-nucleotide exchange factor activity(GO:0030676) |
| 0.1 | 0.5 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
| 0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
| 0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
| 0.1 | 0.1 | GO:0034595 | phosphatidylinositol phosphate 5-phosphatase activity(GO:0034595) |
| 0.1 | 1.1 | GO:0051117 | ATPase binding(GO:0051117) |
| 0.1 | 1.4 | GO:0032813 | tumor necrosis factor receptor superfamily binding(GO:0032813) |
| 0.1 | 0.2 | GO:0005384 | manganese ion transmembrane transporter activity(GO:0005384) |
| 0.1 | 0.2 | GO:0015925 | galactosidase activity(GO:0015925) |
| 0.1 | 1.5 | GO:0005540 | hyaluronic acid binding(GO:0005540) |
| 0.1 | 0.5 | GO:0051428 | peptide hormone receptor binding(GO:0051428) |
| 0.1 | 0.2 | GO:0016499 | orexin receptor activity(GO:0016499) |
| 0.1 | 1.7 | GO:0005523 | tropomyosin binding(GO:0005523) |
| 0.1 | 0.6 | GO:0001619 | obsolete lysosphingolipid and lysophosphatidic acid receptor activity(GO:0001619) |
| 0.1 | 0.2 | GO:0032451 | demethylase activity(GO:0032451) |
| 0.1 | 0.9 | GO:0030169 | low-density lipoprotein particle binding(GO:0030169) |
| 0.1 | 0.3 | GO:0016909 | JUN kinase activity(GO:0004705) SAP kinase activity(GO:0016909) |
| 0.1 | 0.4 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
| 0.1 | 0.8 | GO:0008519 | ammonium transmembrane transporter activity(GO:0008519) |
| 0.1 | 0.1 | GO:0004428 | obsolete inositol or phosphatidylinositol kinase activity(GO:0004428) |
| 0.1 | 1.0 | GO:0004708 | MAP kinase kinase activity(GO:0004708) |
| 0.1 | 2.4 | GO:0047485 | protein N-terminus binding(GO:0047485) |
| 0.1 | 0.2 | GO:0016842 | amidine-lyase activity(GO:0016842) |
| 0.1 | 0.2 | GO:0042834 | peptidoglycan binding(GO:0042834) |
| 0.1 | 0.2 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
| 0.1 | 0.4 | GO:0001968 | fibronectin binding(GO:0001968) |
| 0.0 | 0.3 | GO:0051378 | serotonin binding(GO:0051378) |
| 0.0 | 0.1 | GO:0046790 | virion binding(GO:0046790) |
| 0.0 | 0.1 | GO:0051766 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) inositol trisphosphate kinase activity(GO:0051766) |
| 0.0 | 0.1 | GO:0032794 | GTPase activating protein binding(GO:0032794) |
| 0.0 | 2.0 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
| 0.0 | 2.3 | GO:0008134 | transcription factor binding(GO:0008134) |
| 0.0 | 0.2 | GO:0004875 | complement receptor activity(GO:0004875) |
| 0.0 | 0.1 | GO:0031683 | G-protein beta/gamma-subunit complex binding(GO:0031683) |
| 0.0 | 0.6 | GO:0003841 | 1-acylglycerol-3-phosphate O-acyltransferase activity(GO:0003841) lysophosphatidic acid acyltransferase activity(GO:0042171) lysophospholipid acyltransferase activity(GO:0071617) |
| 0.0 | 0.1 | GO:0003796 | lysozyme activity(GO:0003796) |
| 0.0 | 0.3 | GO:0015016 | [heparan sulfate]-glucosamine N-sulfotransferase activity(GO:0015016) |
| 0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
| 0.0 | 0.6 | GO:0000146 | microfilament motor activity(GO:0000146) |
| 0.0 | 0.2 | GO:0031708 | bombesin receptor binding(GO:0031705) endothelin B receptor binding(GO:0031708) |
| 0.0 | 4.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
| 0.0 | 0.4 | GO:0016564 | obsolete transcription repressor activity(GO:0016564) |
| 0.0 | 0.4 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
| 0.0 | 0.2 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
| 0.0 | 0.3 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) |
| 0.0 | 0.2 | GO:0004996 | thyroid-stimulating hormone receptor activity(GO:0004996) |
| 0.0 | 1.6 | GO:0019903 | protein phosphatase binding(GO:0019903) |
| 0.0 | 0.8 | GO:0004221 | obsolete ubiquitin thiolesterase activity(GO:0004221) |
| 0.0 | 0.1 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
| 0.0 | 0.1 | GO:0031420 | potassium ion binding(GO:0030955) alkali metal ion binding(GO:0031420) |
| 0.0 | 0.7 | GO:0004691 | cAMP-dependent protein kinase activity(GO:0004691) |
| 0.0 | 3.4 | GO:0004896 | cytokine receptor activity(GO:0004896) |
| 0.0 | 0.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
| 0.0 | 0.4 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
| 0.0 | 1.6 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
| 0.0 | 2.5 | GO:0008565 | protein transporter activity(GO:0008565) |
| 0.0 | 1.9 | GO:0005249 | voltage-gated potassium channel activity(GO:0005249) |
| 0.0 | 0.2 | GO:0015187 | glycine transmembrane transporter activity(GO:0015187) glycine:sodium symporter activity(GO:0015375) |
| 0.0 | 0.2 | GO:0008443 | phosphofructokinase activity(GO:0008443) |
| 0.0 | 0.5 | GO:0005267 | potassium channel activity(GO:0005267) |
| 0.0 | 0.5 | GO:0004697 | protein kinase C activity(GO:0004697) |
| 0.0 | 0.6 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
| 0.0 | 2.0 | GO:0008168 | methyltransferase activity(GO:0008168) |
| 0.0 | 0.2 | GO:0070402 | NADPH binding(GO:0070402) |
| 0.0 | 0.1 | GO:0004967 | glucagon receptor activity(GO:0004967) |
| 0.0 | 0.2 | GO:0015185 | gamma-aminobutyric acid:sodium symporter activity(GO:0005332) gamma-aminobutyric acid transmembrane transporter activity(GO:0015185) |
| 0.0 | 0.2 | GO:0004993 | G-protein coupled serotonin receptor activity(GO:0004993) serotonin receptor activity(GO:0099589) |
| 0.0 | 0.1 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
| 0.0 | 3.5 | GO:0051082 | unfolded protein binding(GO:0051082) |
| 0.0 | 0.2 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
| 0.0 | 0.2 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
| 0.0 | 0.1 | GO:0061731 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
| 0.0 | 0.6 | GO:0001614 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
| 0.0 | 0.3 | GO:0008536 | Ran GTPase binding(GO:0008536) |
| 0.0 | 0.1 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
| 0.0 | 0.1 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
| 0.0 | 0.3 | GO:0003857 | 3-hydroxyacyl-CoA dehydrogenase activity(GO:0003857) |
| 0.0 | 0.5 | GO:0004028 | 3-chloroallyl aldehyde dehydrogenase activity(GO:0004028) |
| 0.0 | 0.2 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
| 0.0 | 0.3 | GO:0043325 | phosphatidylinositol-3,4-bisphosphate binding(GO:0043325) |
| 0.0 | 0.2 | GO:0004971 | AMPA glutamate receptor activity(GO:0004971) |
| 0.0 | 3.5 | GO:0000287 | magnesium ion binding(GO:0000287) |
| 0.0 | 0.0 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
| 0.0 | 0.1 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
| 0.0 | 0.2 | GO:0004300 | enoyl-CoA hydratase activity(GO:0004300) |
| 0.0 | 0.3 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
| 0.0 | 0.2 | GO:0004550 | nucleoside diphosphate kinase activity(GO:0004550) |
| 0.0 | 0.4 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
| 0.0 | 0.2 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
| 0.0 | 0.1 | GO:0004445 | inositol-polyphosphate 5-phosphatase activity(GO:0004445) inositol trisphosphate phosphatase activity(GO:0046030) |
| 0.0 | 0.2 | GO:0008510 | sodium:bicarbonate symporter activity(GO:0008510) bicarbonate transmembrane transporter activity(GO:0015106) |
| 0.0 | 0.1 | GO:0004999 | vasoactive intestinal polypeptide receptor activity(GO:0004999) |
| 0.0 | 0.1 | GO:0005497 | androgen binding(GO:0005497) |
| 0.0 | 0.1 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
| 0.0 | 0.1 | GO:0017057 | 6-phosphogluconolactonase activity(GO:0017057) |
| 0.0 | 0.1 | GO:0070063 | RNA polymerase binding(GO:0070063) |
| 0.0 | 0.1 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
| 0.0 | 0.2 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
| 0.0 | 0.1 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
| 0.0 | 0.8 | GO:0017137 | Rab GTPase binding(GO:0017137) |
| 0.0 | 0.1 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
| 0.0 | 0.1 | GO:0001786 | phosphatidylserine binding(GO:0001786) |
| 0.0 | 0.1 | GO:0005160 | transforming growth factor beta receptor binding(GO:0005160) |
| 0.0 | 0.1 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
| 0.0 | 0.1 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
| 0.0 | 0.1 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
| 0.0 | 0.1 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
| 0.0 | 0.1 | GO:0016874 | ligase activity(GO:0016874) |
| 0.0 | 0.1 | GO:0004563 | beta-N-acetylhexosaminidase activity(GO:0004563) |
| 0.0 | 0.1 | GO:0004119 | cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) |
| 0.0 | 0.0 | GO:0010843 | obsolete promoter binding(GO:0010843) |
| 0.0 | 0.1 | GO:0031877 | somatostatin receptor binding(GO:0031877) |
| 0.0 | 0.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
| 0.0 | 0.1 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
| 0.0 | 0.0 | GO:0004167 | dopachrome isomerase activity(GO:0004167) |
| 0.0 | 0.0 | GO:0005148 | prolactin receptor binding(GO:0005148) |
| 0.0 | 0.0 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
| 0.0 | 0.2 | GO:0008527 | taste receptor activity(GO:0008527) |
| 0.0 | 1.8 | GO:0016887 | ATPase activity(GO:0016887) |
| 0.0 | 0.3 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
| 0.0 | 0.0 | GO:0008502 | melatonin receptor activity(GO:0008502) |
| 0.0 | 0.1 | GO:0042923 | neuropeptide binding(GO:0042923) |
| 0.0 | 0.3 | GO:0001972 | retinoic acid binding(GO:0001972) |
| 0.0 | 0.1 | GO:0004969 | histamine receptor activity(GO:0004969) |
| 0.0 | 0.1 | GO:0043236 | laminin binding(GO:0043236) |
| 0.0 | 0.3 | GO:0016563 | obsolete transcription activator activity(GO:0016563) |
| 0.0 | 0.6 | GO:0060090 | binding, bridging(GO:0060090) |
| 0.0 | 0.1 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
| 0.0 | 0.0 | GO:0047977 | hepoxilin-epoxide hydrolase activity(GO:0047977) |
| 0.0 | 0.0 | GO:0003938 | IMP dehydrogenase activity(GO:0003938) |
| 0.0 | 0.0 | GO:0008967 | phosphoglycolate phosphatase activity(GO:0008967) |
| 0.0 | 0.1 | GO:0022829 | wide pore channel activity(GO:0022829) |
| 0.0 | 0.3 | GO:0008066 | glutamate receptor activity(GO:0008066) |
| 0.0 | 2.8 | GO:0004674 | protein serine/threonine kinase activity(GO:0004674) |
Gene overrepresentation in C2:CP category:
| Log-likelihood per target | Total log-likelihood | Term | Description |
|---|---|---|---|
| 0.6 | 36.6 | ST_B_CELL_ANTIGEN_RECEPTOR | B Cell Antigen Receptor |
| 0.4 | 21.6 | ST_T_CELL_SIGNAL_TRANSDUCTION | T Cell Signal Transduction |
| 0.3 | 7.0 | SA_FAS_SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
| 0.2 | 1.1 | ST_PAC1_RECEPTOR_PATHWAY | PAC1 Receptor Pathway |
| 0.2 | 3.7 | SA_G1_AND_S_PHASES | Cdk2, 4, and 6 bind cyclin D in G1, while cdk2/cyclin E promotes the G1/S transition. |
| 0.2 | 1.8 | SIG_IL4RECEPTOR_IN_B_LYPHOCYTES | Genes related to IL4 rceptor signaling in B lymphocytes |
| 0.2 | 1.6 | ST_STAT3_PATHWAY | STAT3 Pathway |
| 0.2 | 6.9 | ST_DIFFERENTIATION_PATHWAY_IN_PC12_CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
| 0.2 | 3.9 | ST_INTERLEUKIN_4_PATHWAY | Interleukin 4 (IL-4) Pathway |
| 0.1 | 3.0 | ST_ERK1_ERK2_MAPK_PATHWAY | ERK1/ERK2 MAPK Pathway |
| 0.1 | 3.4 | ST_PHOSPHOINOSITIDE_3_KINASE_PATHWAY | PI3K Pathway |
| 0.1 | 2.6 | SA_CASPASE_CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
| 0.1 | 3.7 | SA_MMP_CYTOKINE_CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
| 0.1 | 3.4 | SIG_INSULIN_RECEPTOR_PATHWAY_IN_CARDIAC_MYOCYTES | Genes related to the insulin receptor pathway |
| 0.1 | 1.6 | SIG_BCR_SIGNALING_PATHWAY | Members of the BCR signaling pathway |
| 0.1 | 2.4 | ST_G_ALPHA_I_PATHWAY | G alpha i Pathway |
| 0.1 | 3.9 | ST_INTEGRIN_SIGNALING_PATHWAY | Integrin Signaling Pathway |
| 0.0 | 0.4 | SA_PTEN_PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
| 0.0 | 0.4 | SA_REG_CASCADE_OF_CYCLIN_EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
| 0.0 | 0.8 | ST_WNT_CA2_CYCLIC_GMP_PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
| 0.0 | 0.0 | ST_G_ALPHA_S_PATHWAY | G alpha s Pathway |
| 0.0 | 0.1 | ST_JAK_STAT_PATHWAY | Jak-STAT Pathway |
| 0.0 | 0.9 | ST_JNK_MAPK_PATHWAY | JNK MAPK Pathway |
|
|
|